Investigator Grants (1215)
2013 | ||
|
Title: (PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies Sponsor: National Institutes of Health (NIH) |
||
|
Title: (PQD5) DNA Damage in Circulating Tumor Cells Predicts Chemotherapy Outcome Sponsor: National Institutes of Health (NIH) |
||
|
Title: 2012-2013 UNC Nutrition Obesity Research Center Progress Report Sponsor: NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDKD) |
||
|
Title: 2013 Clinical Research Mentorship Sponsor: Doris Duke Charitable Foundation |
||
|
Title: 205.478 A randomized, placebo-controlled, double-blind, parallel group, multi center study to assess the safety and efficacy of tiotropium bromide (18 g) delivered via the HandiHaler in Chronic Obstructive Pulmonary Disease (COPD) subjects recovering from hospitalization for an acute exacerbation (Hospital Discharge Study 2) Sponsor: Boehringer Ingelheim Pharmaceuticals, Inc. |
||
|
Title: A Chemical Genetic Approach for Activating the Dormant Gene Associated with Rett Syndrome Sponsor: Rett Syndrome Research Trust |
||
|
Title: A multi-center outpatient trail of a bihormonal bionic pancreas Sponsor: Boston University |
||
|
Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate
Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects
with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for
Cardiovascular Events
TAK-875, 50 mg CV Outcomes Study Sponsor: Quintiles, Inc |
||
|
Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate
Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects
with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for
Cardiovascular Events
TAK-875, 50 mg CV Outcomes Study Sponsor: Takeda Global Research and Development Center, Inc. |
||
|
Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients with Type 2 Diabetes Sponsor: Quintiles, Inc |
||
|
Title: A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week
Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Adult Subjects of
Black Race with Systemic Lupus Erythematosus (SLE) Sponsor: Human Genome Sciences, Inc. |
||
|
Title: A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF AEROVANC FOR THE TREATMENT OF PERSISTENT METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS LUNG INFECTION IN CYSTIC FIBROSIS PATIENTS Sponsor: Savara Inc |
||
|
Title: A Randomized, Double-Blind, Placebo-Controlled
Study Comparing CroFab versus Placebo with Rescue Treatment for Copperhead Snake Envenomation" Sponsor: BTG International, Ltd, |
||
|
Title: ACCORDION Sponsor: Wake Forest University School of Medicine |
||
|
Title: ACTG, AIDS Clinical Trial Research Group-A5272;A5280;A5254;A5311 Sponsor: Brigham and Womens Hospital |
||
|
Title: Addiction and the ability to establish and to overcome habitual responses Sponsor: National Institutes of Health (NIH) |
||
|
Title: Adenosine receptors as therapeutic targets for chronic rhinosinusitis Sponsor: National Institutes of Health (NIH) |
||
|
Title: Advanced Education Nursing Traineeship Program Sponsor: Bureau of Health Professions (BHP) |
||
|
Title: An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and
Tolerability of ITCA 650 in Patients with Type 2 Diabetes with High Baseline
HbA1c Investigational Product: Exenatide in DUROS Device (ITCA 650)
Protocol Number: ITCA 650-CLP-103-Sub-study Sponsor: Quintiles, Inc |
||
|
Title: Application of Omics in Lung Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: ARFI-Monitored Hemostatic Challenge for In Vivo Hemostasis Monitoring: Repeatability and Response to Therapy in Dogs with Hemophilia A Sponsor: Novo Nordisk Pharmaceuticals |
||
|
Title: Assessing the association between hormonal dysregulation, postpartum depression, pain sensitivity and adverse life events among lactating Spanish-speaking Latina mothers: A pilot study Sponsor: Foundations of Hope |
||
|
Title: Bioequivalence and Pharmacogenomics of IR, SR, and XL Generic Bupropion
in Healthy Volunteers Sponsor: DHHS Food and Drug Administration (FDA) |
||
|
Title: BLT model of latency and eradication: the myeloid compartment and the CNS Sponsor: National Institutes of Health (NIH) |
||
|
Title: Bromodomain-targeting compounds as new latency-purging agents in HIV infections Sponsor: National Institutes of Health (NIH) |
||
|
Title: Cancer Health Disparities Training Program Sponsor: NIH National Cancer Institute (NCI) |
||
|
Title: CanSecure: A Secure Computing Vault (Work Space) for Cancer Research Sponsor: National Institutes of Health (NIH) |
||
|
Title: CARE Community Advisory Board (CAB) - Administrative Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: Cellular Determinants of Thrombus Structure and Stability Sponsor: National Institutes of Health (NIH) |
||
|
Title: CFTR structure, function and response to modulators Sponsor: Cystic Fibrosis Foundation |
||
|
Title: Change in Opioid use and overdose after a medicaid lock-in program Sponsor: Centers for Disease Control and Prevention (CDC) |
||
|
Title: CHDH and sperm function: Effects of betaine. Sponsor: National Institutes of Health (NIH) |
||
|
Title: CIB1 regulation of endothelial function Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI) |
||
|
Title: CIB1 regulation of integrin alphaV beta3 activation and function in endothelial cells Sponsor: American Heart Association (AHA) |
||
|
Title: Clinical Translational Research Center for Neurodevelopmental Disorders Sponsor: NIH National Institute of Child Health and Human Development (NICHD) |
||
|
Title: Comparing Three Strategies for Increasing Value Concordant Decisions About Cervical Cancer Screening. Sponsor: Patient-Centered Outcomes Research Institute (PCORI) |
||
|
Title: CONSISTENT 1: Evaluation of Metabolic Outcomes and Safety of Hylenex recombinant (hyaluronidase human injection) used as a Preadministration Infusion Site Treatment in Subjects with Type 1 Diabetes (T1DM) Using Continuous Subcutaneous Insulin Infusion (CSII) Sponsor: Halozyme, Inc. |
||
|
Title: Core B CHAVI 001 Lilongwe Sponsor: Duke University |
||
|
Title: Defining Treatment Parameters for Angelman Syndrome Sponsor: Angelman Syndrome Foundation |
||
|
Title: Dental Toolkit for UCSF Sponsor: University of California at San Francisco (UCSF) |
||
|
Title: Development of a Preclinical Model for Social Deficits in Autism Sponsor: Department of Defense (DOD) |
||
|
Title: Differential regulation of autoimmune arthritis by monocyte subsets Sponsor: NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) |
||
|
Title: Directly Reprogrammed Human Neural Stem Cells for Cancer Therapy Sponsor: NIH National Cancer Institute (NCI) |
||
|
Title: EFC12456 A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus
Injected in the Morning or Evening in Patients with Type 1 Diabetes Mellitus with a
6-month Safety Extension Period Sponsor: Jaeb Center for Health Research Foundation |
||
|
Title: Effect of clot composition on thrombus resolution Sponsor: National Institutes of Health (NIH) |
||
|
Title: Effect of swim training on physical characteristics in youth swimmers Sponsor: National Athletic Trainers Association (NATA) Research and Education Foundation |
||
|
Title: Effects of Custom Foot Orthoses on Balance and Falls in Older Adults Sponsor: National Institutes of Health (NIH) |
||
|
Title: Epigenetic Regulation of Ube3a as a Treatment for Angleman Syndrome Sponsor: NIH National Institute of Mental Health (NIMH) |
||
|
Title: Evaluate the immunogenicity of an IL-12 pDNA enhanced HIV-1 multigene pDNA prime Sponsor: National Institutes of Health (NIH) |
||
|
Title: Evaluating new gene regulators of HIV Latency in primary CD4 T cells Sponsor: National Institutes of Health (NIH) |
||
|
Title: Evaluation of CFQ-R in the Context of Primary Ciliary Dyskinesia Sponsor: University of Miami |
||
|
Title: FL3X: An Adaptive Intervention to Improve Outcomes for Youth with Type 1 Diabetes Sponsor: National Institutes of Health (NIH) |
||
|
Title: Genome-Wide Association Study of ACCORD Lipid Trial Sponsor: National Institutes of Health (NIH) |
||
|
Title: Giant Axonal Neuropathy Gene Therapy Sponsor: National Institutes of Health (NIH) |
||
|
Title: GS-US-236-0128 A Randomized, double-blinded Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Nave Women Sponsor: Gilead Sciences, Inc. |
||
|
Title: Healthy Places North Carolina (HPNC) - Phase I Evaluation. Sponsor: University of North Carolina at Greensboro (UNCG) |
||
|
Title: Hemophilia Inhibitor Pup Study Sponsor: University of Texas at Houston Health Sciences Center |
||
|
Title: HIV Care in Malawi: Gilead Training Fellowship Sponsor: Gilead Foundation |
||
|
Title: HPTN 069 Qualitative Interview Sponsor: Duke University |
||
|
Title: Implementing and Assessing Behavior, Access and Support Intervention to Cope with Sickle Cell Disease (BASICS) study to Enhance Quality of Life and Health Outcomes for Adults with Sickle Cell Disease in North Carolina. Sponsor: University of North Carolina at Greensboro (UNCG) |
||
|
Title: Improving the Supervision of Probationers with Mental Illness Sponsor: National Institute of Justice |
||
|
Title: Incorporating geography and genetics: Transmission patterns & drug resistance in HIV in North Carolina Sponsor: University of Iowa |
||
|
Title: Interaction between curcumin & irinotecan in colorectal cancer chemotherapy Sponsor: American Cancer Society (ACS) |
||
|
Title: Interaction between curcumin and irinotecan for colorectal cancer chemotherapy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Interrogation of platelet AADACL1 via targeted lipidomics and in vivo models of thrombosis Sponsor: American Heart Association (AHA) |
||
|
Title: Keeping the promises of translational research: Will biobank speciments be used? Sponsor: National Institutes of Health (NIH) |
||
|
Title: Martin Delaney Collaboratory to Eradicate HIV-1 Infection Year 2 - 3rd Administrative Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mast cells and environmental asthma-LPS Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mechanisms of HIV-related Lung Disease Cooperative Agreement Data Coordinating Center Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI) |
||
|
Title: Mechanisms of Paneth Cell Antimicrobial Peptide Abnormalities Induced by Crohn's Disease-related Genetic defects in Autophagy Sponsor: Crohns and Colitis Foundation of America (CCFA) |
||
|
Title: Mechanisms of PPAR-gamma Enhancement of Cognitive Function in Alzheimer's Disease Sponsor: University of Texas Medical Branch at Galveston (UTMB) |
||
|
Title: Mechanisms Underlying Drug-Diet Interactions- Collaborative Science Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: Molecular Mechanisms Associated with Immune Maturation in Infants Sponsor: NIH National Institute of Allergy and Infectious Diseases (NIAID) |
||
|
Title: Multi-Institutional Kidney Cancer SPORE Sponsor: University of Texas MD Anderson Cancer Center |
||
|
Title: Network Group Integrated Translational Science Centers Application Sponsor: National Institutes of Health (NIH) |
||
|
Title: Pharmacokinetics and pharmacodynamics of calcitriol 3mcg/g ointment applied twice daily for 14 days under conditions of maximal use in pediatric subjects (2 to 12 years of age) with plaque psoriasis Sponsor: Premier Research Group |
||
|
Title: Preliminary Proposal:Interneuronal Synaptic Elimination in Cortical Circuit Development Sponsor: National Science Foundation (NSF) |
||
|
Title: Project 1 and 2; Pilot 1 Clinical Trials Sponsor: Fred Hutchinson Cancer Research Center |
||
|
Title: Protease-activated receptors in allergic fungal rhinosinusitis Sponsor: American Academy of Otolaryngic Allergy (AAOA) |
||
|
Title: Protocol B5K-US-IBHC Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily versus Twice-Daily) in Subjects with Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy with or without Oral Agents: A Randomized, Open-Label,
Parallel Clinical Trial Sponsor: Lilly USA LLC |
||
|
Title: Quantitative Viral Outgrowth Assay Resource for MDC U19 - CARE Year 3 Sponsor: National Institutes of Health (NIH) |
||
|
Title: Reducing Risk of Cardiovascular Disease Risk Factors in Rural Communities in NC, Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI) |
||
|
Title: Region 3 Collaborative Genetic and Newborn Screening Services Core Grant Activities Sponsor: Georgia Southern University |
||
|
Title: Regulation of Spine Morphogenesis by NrCAM Sponsor: NIH National Institute of Mental Health (NIMH) |
||
|
Title: RFHE4044 A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy of Rifaximin 550 MG With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy Sponsor: Salix Pharmaceuticals, Inc. |
||
|
Title: RPB Unrestricted Grant Sponsor: Research to Prevent Blindness (RPB) |
||
|
Title: SCP Impact on Cardiovascular Care & Outcomes in Prostate Cancer Survivors, a RCT Sponsor: American College of Radiology (ACR) |
||
|
Title: Secondary Analyses of Osteoporosis Screening in Older Men Sponsor: National Institutes of Health (NIH) |
||
|
Title: SFRP2 and NFAT are therapeutic targets in angiosarcoma Sponsor: NIH National Cancer Institute (NCI) |
||
|
Title: Simple interventions to Improve Rotavirus Vaccine Effectiveness (SIRVE) Sponsor: National Institutes of Health (NIH) |
||
|
Title: Soluble epoxide hydrolase and cardioprotection: translation from mice to humans Sponsor: AHA Mid-Atlantic Affiliate (DC, MD, NC, SC, VA) |
||
|
Title: Specialty Mental Health Probation Officers in North Carolina Sponsor: North Carolina Department of Public Safety |
||
|
Title: Supporting the Safe Motherhood Initiative in Malawi Sponsor: Bill and Melinda Gates Foundation |
||
|
Title: Targeting DNA Neutrophil Extracellular Traps in Sickle Cell Disease Sponsor: Doris Duke Charitable Foundation |
||
|
Title: Targeting State-Dependent Cortical Oscillations with Brain Stimulation Sponsor: National Institutes of Health (NIH) |
||
|
Title: Targeting VAMP8 to reduce mucin secretion and mast cell degranulation in asthma Sponsor: American Asthma Foundation (AAF) |
||
|
Title: The Childhood Obesity Policy and Comparative Effectiveness Model (COPCEM) Sponsor: University of Alabama at Birmingham |
||
|
Title: The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet: A Longitudinal Investigation in the Second and Third Trimesters Including Empiric Dosage Adjustment Sponsor: AbbVie, Inc. |
||
|
Title: The Forum HIV Cure Project: Focus on Regulatory Issue Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Role of Interleukin-2 Inducible T cell Kinase in Cutaneous Melanoma Sponsor: Harry J Lloyd Charitable Trust |
||
|
Title: the UNC-UNZA Training Program for HIV and Women's Health Sponsor: National Institutes of Health (NIH) |
||
|
Title: To identify potential candidates for effective antioxidant therapy of atherosclerosis using novel mouse models Sponsor: AHA Mid-Atlantic Affiliate (DC, MD, NC, SC, VA) |
||
|
Title: Treating Co-occurring Substance Use and Mental Disorders among Jail Inmates Sponsor: Research Triangle Institute (RTI International) |
||
|
Title: Treatment for male infertility Sponsor: Metagenics, Inc. |
||
|
Title: University of North Carolina AIDS Clinical Trials Unit-HPTN 069 Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit Sponsor: National Institutes of Health (NIH) |
||
|
Title: Using NK Cells to eliminate the latent HIV reservoir Sponsor: National Institutes of Health (NIH) |
||
|
Title: Using Phylogenetics to Elucidate HIV Transmission Patterns and Inform Prevention Sponsor: National Institutes of Health (NIH) |
||
|
Title: Variations in Hip Morphology: Frequency and Impact on Osteoarthritis Outcomes Sponsor: NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) |
||
|
Title: Yo Veo Sponsor: Z Smith Reynolds Foundation |
||
| ||
|
Title: "A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Nave Patients Infected with R5-Tropic HIV-1." BRS-ACURE-S-12-002348 Sponsor: Social and Scientific Systems (S3), Inc. |
||
|
Title: "Change in Opioid use and overdose after a medicaid lock-in program" Sponsor: National Center for Injury Prevention and Control (NCIPC) |
||
|
Title: (PQD5)Predicting chemotherapy effects by measuring DNA damage in tumor subpopulations Sponsor: National Institutes of Health (NIH) |
||
|
Title: 12R-MC-BIAO The Impacy of LY2605541 versus Insulin Glargine for Patients with Type 1 Diabetes Mellitus Treated with Prepandial Insulin Lispro: a Double Blind, Randomized, 52 Week Study Sponsor: Eli Lilly and Co. |
||
|
Title: 2/3-Improving Metabolic Parameters of Antipsychotic Child Treatment Sponsor: National Institutes of Health (NIH) |
||
|
Title: A Collaborative Model to Improve BP Control and Minimize Racial Disparities - CCC Sponsor: University of Iowa |
||
|
Title: A Knowledge Base for Clinically Relevant Genes and Variants Sponsor: National Institutes of Health (NIH) |
||
|
Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Occurrence of Major Adverse Cardiovascular Events (MACE) in Overweight and Obese Subjects With Cardiovascular Risk Factors Receiving Naltrexone SR/Bupropion SR Sponsor: Orexigen Therapeutics, Inc. |
||
|
Title: A novel antioxidant mouse model for effective antioxidant therapy Sponsor: American Diabetes Association (ADA) |
||
|
Title: A Novel Approach for Treatment for Unresectable Angiosarcoma:Ultrasound Treatment with SFRP2 Molecularly Targeted Microbubbles Sponsor: The Kristen Ann Carr Fund |
||
|
Title: A novel mouse model of diabetic nephropathy for studying antioxidant intervention Sponsor: National Institutes of Health (NIH) |
||
|
Title: A novel murine antioxidant model for study of diabetic nephropathy Sponsor: National Institutes of Health (NIH) |
||
|
Title: A Novel, Data-Driven Approach to Food Safety and Nutrition Policy Analysis Sponsor: Center for Foodborne Illness Research and Prevention |
||
|
Title: A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Nave Patients Infected with R5-Tropic HIV-1
BRS-ACURE-S-12-002348 Sponsor: Social and Scientific Systems (S3), Inc. |
||
|
Title: A pragmatic assessment of glucose monitoring in non-insulin treated diabetes Sponsor: NIH National Center for Complementary and Alternative Medicine |
||
|
Title: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy BRS-ACURE-S-12-002213 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: A Study to Evaluate Cardiovascular Risk Factors and Receipt of Primary and Preventive Care in Prostate Cancer Patients who Receive Definitive Radiation Therapy and Androgen Deprivation Therapy Sponsor: Radiation Therapy Oncology Group (RTOG) |
||
|
Title: A Web-Based Intervention to Improve Adherence to CHD Prevention Medications Sponsor: National Institutes of Health (NIH) |
||
|
Title: A5260s (UWAS1)- Subcontract No. CRB-SSS-S-12-002604 Sponsor: Social and Scientific Systems (S3), Inc. |
||
|
Title: AAV-MEDIATED GLOBAL GENE THERAPY FOR THE TREATMENT OF
TAY-SACHS DISEASE Sponsor: New Hope Foundation |
||
|
Title: Academic-Community Partnership Conference Series (R13) Sponsor: National Institutes of Health (NIH) |
||
|
Title: ACT 12374 A randomized, 24 week, open-label, 2 arm parallel-group, multicenter study comparing the efficacy and safety of insulin glargine/lixisenatide fixed ratio combination versus insulin glargine on tope of metformin in type 2 diabetic patients Sponsor: Sanofi-Aventis |
||
|
Title: Adipocytokines, glucose tolerance and myocardial infarction in HIV infection Sponsor: University of Alabama at Birmingham |
||
|
Title: Advance Care Planning and Post-Stroke Management for Older Adults Sponsor: Patient-Centered Outcomes Research Institute (PCORI) |
||
|
Title: AIDS Clinical Trials Group Network ("ACTG")-BRS-ACURE-S-12-000080-002314 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: AIDS Clinical Trials Group Network ("ACTG")-BRS-ACURE-S-12-000080-002314-001 Sponsor: Social and Scientific Systems (S3), Inc. |
||
|
Title: Alcohol-Related Injuries in Adolescents and Young Adults Seen in an Emergency Department Sponsor: Peter McManus Charitable Trust |
||
|
Title: Amigas Latinas Motivando el Alma (ALMA) Plus Bridge Sponsor: Duke University |
||
|
Title: Amigas Latinas Motivando el Alma(ALMA) Expansion of a Depression Prevention Model Sponsor: Duke University Medical Center |
||
|
Title: An Adaptive Intervention to Improve Outcomes for Youth with Type 1 Diabetes Sponsor: National Institutes of Health (NIH) |
||
|
Title: An Erythropoietin-Mimetic Peptide for Treatment of TBI Sponsor: Baylor College of Medicine |
||
|
Title: Automated MRI Segmentation and Quantification of Duchenne Muscular Dystrophy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Automated Quantification of Muscle MRI in Duchenne Muscular Dystrophy Sponsor: Muscular Dystrophy Association (MDA) |
||
|
Title: BESTCILIA Sponsor: European Commission |
||
|
Title: Betaine as a treatment for asthenospermia in men with SNPs in CHDH Sponsor: National Institutes of Health (NIH) |
||
|
Title: BPI 1001-11-e-CAESAR Evaluation of a Cognitively Adaptive e-treatment in Schizophrenia-diagnosed Adults: A Remediation-based Approach Sponsor: Brain Plasticity, Inc. |
||
|
Title: Breastfeeding Support Innovation, Evaluation and Replication: Reaching Underserved Populations through Translation of Research into Program Interventions Sponsor: W. K. Kellogg Foundation |
||
|
Title: Breathing Exercises to Help Adult Inpatients with Sickle Cell Manage Pain Sponsor: NIH National Institute of Nursing Research (NINR) |
||
|
Title: BRS-ACURE-S-11-000080-001824 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: BRS-ACURE-S-11-000080-002070 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: Cardiovascular, anthropometric, and skeletal effects of anti-retroviral (ARV) initiation with tenofovir/emtricitabine plus atazanavir/ritonavir (ATV/r), darunavir/ritonavir (DRV/r), or raltegravir (RTG): Metabolic Substudy of A5257-Subcontract No. CRB-UCLA1-S-10-00048 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: Center for Genomics and Society Sponsor: NIH National Human Genome Research Institute (NHGRI) |
||
|
Title: Center for HIV/AIDS Vaccine Immunology (CHAVI) 001 Lilongwe Site Sponsor: Duke University |
||
|
Title: CHAVI ID Lilongwe Sponsor: Duke University |
||
|
Title: CHAVI ID-012 Eron Sponsor: Duke University |
||
|
Title: CIB1 regulation of endothelial function Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: Cigarette smoke, viral infections & NK cells Sponsor: Flight Attendant Medical Research Institute, Inc. |
||
|
Title: Clinical Evaluation of the Contact Therapy Cool Path Cardiac Ablation System in Conjunction with EnSite Velocity Contact Technology for the Treatment of Typical Atrial Flutter (CONTACT AFL) Sponsor: St. Jude Medical |
||
|
Title: Clinical Lab Test of Chemotherapy-Induced DNA Damage in Circulating Tumor Cells Sponsor: National Institutes of Health (NIH) |
||
|
Title: Coagulation factor replacement to support normal joint and osteochondral healing Sponsor: Baxter Bioscience |
||
|
Title: Community-Based Partnerships for Shared Use of Physical Activity Facilities Sponsor: North Carolina State University |
||
|
Title: Comparative safety of antiretrovirals among HIV-infected patients: minimizing coronary heart disease outcomes Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Developing a mobile health application to help adolescents self-manage their asthma Sponsor: American Lung Association |
||
|
Title: Development of a Neuroimaging Network for the ACTG 5310: Site Screening and Preparation Sponsor: Washington University in St. Louis School of Medicine |
||
|
Title: Development of nanoparticle formulations of DNA double-strand break repair inhibitors to improve chemoradiotherapy Sponsor: Lung Cancer Research Foundation |
||
|
Title: Development of Stop Consonants in Children with Repaired Cleft Palate Sponsor: National Institutes of Health (NIH) |
||
|
Title: Directed Evolution of Novel AAV Capsids for Global CNS Delivery in Primates Sponsor: National Institutes of Health (NIH) |
||
|
Title: Director of Molecular Pathology for the Alliance for Clinical Trials in Oncology Sponsor: University of Chicago |
||
|
Title: Dissemination of Intervention to Reduce HIV/STIs in African American Rural Youth Sponsor: National Institutes of Health (NIH) |
||
|
Title: Doris Duke Charitable Foundation International Clinical Research Fellowships for Medical Students Sponsor: Doris Duke Charitable Foundation |
||
|
Title: Early MRSA Therapy in CF - Culture-based vs. observant therapy (treat or observe) Sponsor: Cystic Fibrosis Foundation Therapeutics, Inc. |
||
|
Title: Effect of a Medicaid Lock-In Program on Controlled Substance Use and Overdose Sponsor: National Institutes of Health (NIH) |
||
|
Title: Engineering Career Development Center in Movement and Rehabilitation Sciences Sponsor: Northwestern University |
||
|
Title: Enhancing Cognition by Pacing of Cortical Network Dynamics with Non-Invasive Brain Stimulation Sponsor: US Defense Advanced Research Project Agency |
||
|
Title: Enhancing Translational Science via Prospective Investigation Sponsor: National Institutes of Health (NIH) |
||
|
Title: Envisioning Health: Using Images to Enhance Relationships between Latino Adolescents and Health Care Providers Sponsor: NIH Office of Behavioral and Social Sciences Research (OBSSR) |
||
|
Title: Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network Sponsor: Duke University Medical Center |
||
|
Title: EX2211-3748 Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results: A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events LEADER Sponsor: Novo Nordisk |
||
|
Title: Examining the Role of CGM in Non-Insulin Treated Type 2 Diabetes Proposed Budget Detail Sponsor: Medtronic MiniMed, Inc. |
||
|
Title: Examining the Role of Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes Sponsor: Medtronic, Inc. |
||
|
Title: Family members influence quality and delivery of care for heart failure patients Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI) |
||
|
Title: First Annual UNC-NCSU Rehabilitation Engineering Center Symposium: Engineering a World Class Rehabilitation Center Sponsor: NC Biotechnology Center |
||
|
Title: FIXED PRICE SUBCONTRACT BETWEEN HAGER SHARP, INC. WASHINGTON, D. C.
AND UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL/
UNC DIABETES CARE CENTER Sponsor: Hager Sharp, Inc. |
||
|
Title: GLOBAL GENE TRANSFER FOR THE TREATMENT OF BATTEN DISEASE Sponsor: The Saoirse Foundation |
||
|
Title: Hemozoin Breakers: A novel class of anti-malarial compounds Sponsor: National Institutes of Health (NIH) |
||
|
Title: HIV in Semen-Effects of Antiviral Therapy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Home-Collected Blood Spots to Increase HIV Test Frequency among Young Black MSM Sponsor: National Institutes of Health (NIH) |
||
|
Title: How do RA patients process DMARD information: a pilot study Sponsor: Arthritis Foundation |
||
|
Title: HPTN 069 and HPTN 073 Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: HPTN 069 Qualitative Interview Sponsor: Duke University Clinical Research Institute |
||
|
Title: I2R-MC-BIAO The Impact of LY2605541 versus Insulin Glargine for Patients with Type 1 Diabetes Mellitus Treated with Preprandial Insulin Lispro: a Double-Blind, Randomized, 52-week Study IMAGINE 3 Study Sponsor: Eli Lilly and Company |
||
|
Title: I2R-MC-BIDJ A Comparison of LY2605541 versus Insulin Glargine Alone or in Combination with Pre-study Oral Antihyperglycemic Medications in Patients with Type 2 Diabetes Mellitus Previously Treated with Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study Sponsor: Eli Lilly and Company |
||
|
Title: Identification of mislocalized presynaptic transcripts in Fragile X Sponsor: Simons Foundation |
||
|
Title: IM129-008-002 A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Crohn's Disease (CD) Sponsor: Bristol-Myers Squibb Company |
||
|
Title: Immediate Postplacental Insertion of the Intrauterine Device at Time of Cesarean: A Randomized Control Trial Sponsor: Society of Family Planning |
||
|
Title: Impact of Sex Chromosome Complement on Postnatal Development of Neural Circuits Sponsor: National Institutes of Health (NIH) |
||
|
Title: Implementing patient reported outcomes in FQHCs: A feasibility study Sponsor: NIH National Cancer Institute (NCI) |
||
|
Title: Improving the Specificity of Breast Ultrasound through SFRP2 Targeted Imaging Sponsor: Susan G Komen for the Cure |
||
|
Title: Incoming Subcontract from University of Washington - Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1) Sponsor: NIH National Center for Advancing Translational Sciences (NCATS) |
||
|
Title: IND 108186 Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients with Schizophrenia Stabilized on Lurasidone Sponsor: Research Foundation for Mental Hygiene, Inc |
||
|
Title: Insight FLU 002 An International Observational Study to Characterize Adults with Influenza INFLUENZA OUTPATIENT STUDY Sponsor: Institute for Clinical Research, Inc. |
||
|
Title: Insight FLU 003 An International Observational Study to Characterize Adults Who Are Hospitalized with Complications of Influenza INFLUENZA HOSPITALIZATION STUDY Sponsor: Institute for Clinical Research, Inc. |
||
|
Title: Integrated Health Sciences Facility Core Sponsor: North Carolina State University |
||
|
Title: Intensive Rehabilitation Research Grant Writing Workshops in the United States Sponsor: National Institute of Child Health and Human Development (NICHD) |
||
|
Title: Interaction between curcumin and irinotecan in colorectal cancer chemotherapy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Intraoperative Monitoring During Human Cochlear Implantation Sponsor: American Academy of Otolaryngology-Head and Neck Fdn., Inc |
||
|
Title: Investigation and Validation of a Gene Therapy Approach for Giant Axonal Neuropathy Sponsor: Hannahs Hope Fund |
||
|
Title: Krabbe Translational Research Network (KTRN) Therapy for Krabbe Disease Sponsor: Children's Hospital of Pittsburgh |
||
|
Title: Krabbe Translational Research Network (KTRN) Therapy for Krabbe Disease Sponsor: University of Pittsburgh |
||
|
Title: LAI116482 A Phase IIb, dose ranging study of oral GSK1265744 in combination with nucleoside reverse transcriptase inhibitors for induction of HIV-1 virologic suppression followed by an evaluation of maintenance of virologic suppression when oral GSK1265744 is combined with oral rilpivirine in HIV-1 infected, antiretroviral therapy naive adult subjects Sponsor: GlaxoSmithKline (GSK), Inc. |
||
|
Title: Leadership Group for a Clinical Research Network on Integrated Strategies to Prevent HIV Infection (UM1)-HIV/AIDS Prevention Network (HPTN) Sponsor: Family Health International |
||
|
Title: LPV PK in HIV-Infected Pregnant Women Sponsor: Abbott Laboratories Corp. |
||
|
Title: Maintenance of Animal Models of Human Hemophilia and vWD Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI) |
||
|
Title: Managing Childhood Obesity with Virtual Gaming Technology Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mapping of NCAM-regulated Inhibitory Circuits in Mouse Prefrontal Cortex by Optogenetic Stimulation Sponsor: National Alliance Res on Schizophrenia and Depression (NARSAD) |
||
|
Title: Martian Delaney Collaboratory to Eradicate HIV-1 Invection Year 2 Administrative Suppllement Sponsor: National Institutes of Health (NIH) |
||
|
Title: Martin Delaney Collaboratory to Eradicate HIV-1 Infection Sponsor: NIH National Institute of Allergy and Infectious Diseases (NIAID) |
||
|
Title: Martin Delaney Collaboratory to Eradicate HIV-1 Infection Administrative Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: mec116180 Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212 Sponsor: GlaxoSmithKline, Inc |
||
|
Title: Mentoring in community influences on CVD risk Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI) |
||
|
Title: MET-PCD-02 A randomized, double-blind, placebo-controlled study of the efficacy and safety of metronidazole ointment in symptomatic perianal Crohn's disease Sponsor: Braintree Laboratories, Inc. |
||
|
Title: Metadata Analysis for Population-based Management of Diabetic Retinopathy Sponsor: University of Tennessee |
||
|
Title: Mindfulness Meditation for Pain Management in Young Adults with Sickle Cell Sponsor: NIH National Center for Complementary and Alternative Medicine |
||
|
Title: Molecular Mechanisms of Inhibitory Circuit Development Sponsor: National Institutes of Health (NIH) |
||
|
Title: More and better lungs: Ex-vivo perfusion of lungs from non-heart-beating donors Sponsor: National Institutes of Health (NIH) |
||
|
Title: mTOR as a Potential Therapeutic Target in SLE Sponsor: Lilly Research Laboratories |
||
|
Title: Multifunctional Nanoconjugates for Targeting Therapeutic Oligonucleotides to Ovarian Cancer Sponsor: National Institutes of Health (NIH) |
||
|
Title: Nanoparticle Agents for the Treatmetn of Metastatic and Central Nervous System Malignancies Sponsor: American Brain Tumor Association |
||
|
Title: Nanoparticle formulations of DNA repair inhibitors to improve chemoradiotherapy Sponsor: National Institutes of Health (NIH) |
||
|
Title: NIAMS Multidisciplinary Clinical Research Center Sponsor: National Institutes of Health (NIH) |
||
|
Title: NN1250-3944 The effect of Insulin Degludec in combination with Liraglutide and Metformin compared to Liraglutide and Metformin in subjects with Type 2 Diabetes qualifying for treatment intensification Sponsor: Novo Nordisk |
||
|
Title: NN9068-3912 A trial comparing the efficacy and safety of insulin degludec/liraglutide and insulin degludec in subjects with type 2 diabetes Sponsor: Novo Nordisk A/S |
||
|
Title: Novel correctors of CFTR folding defects Sponsor: Parion Sciences |
||
|
Title: Novel genetic mouse models and successful antioxidant therapy for atherosclerosis Sponsor: National Institutes of Health (NIH) |
||
|
Title: Novel magnetic resonance approach to detect BAT distribution and temperature Sponsor: National Institutes of Health (NIH) |
||
|
Title: Optimiizing Technology in the Treatment of Bulimia Nervosa Sponsor: National Institutes of Health (NIH) |
||
|
Title: Osteoporosis screening in younger postmenopausal women and older men Sponsor: American Society for Bone and Mineral Research (ASBMR) |
||
|
Title: Ovarian Cycle Hormones and the Neurobiology of Impulsive Choice Sponsor: National Institutes of Health (NIH) |
||
|
Title: Pathophysiology of hypercoagulability and thrombosis Sponsor: American Heart Association - Mid Atlantic Affiliate |
||
|
Title: Pediatric Trial Network Opportunity #1 (TO6) Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care Sponsor: Duke University |
||
|
Title: Persistent Pain and Associated Physical Function Decline Among Elderly Indivduals Experiencing Minor Motor Vehicle Collision Sponsor: National Institutes of Health (NIH) |
||
|
Title: Phenotypic Markers of Reduced Stromal-Epithelial Cell Ratios for Diagnosis of EIN Sponsor: University of Texas MD Anderson Cancer Center |
||
|
Title: Philadelphia Roadmap to Health Equity in MCH Sponsor: WK Kellogg Foundation |
||
|
Title: Physical Activity, Sedentary Behavior, and Natural Fertility Sponsor: National Institutes of Health (NIH) |
||
|
Title: PZP114828 Neoadjuvant Pazopanib: A Phase II Study to Evaluate the Effect on Disease Recurrence and Establish Predictive Biomarkers of Drug Activity Sponsor: GlaxoSmithKline (GSK), Inc. |
||
|
Title: Quantitative Assessment and Diagnosis of Apraxia of Speech Sponsor: National Institutes of Health (NIH) |
||
|
Title: Region 3 Collaborative Genitic and Newborn Screening Services Core Grant Activities Sponsor: University of North Carolina at Greensboro (UNCG) |
||
|
Title: Reproducibility and Clinical Implications of Masked Hypertension Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI) |
||
|
Title: Restoration of mutant CFTR stability and function Sponsor: NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDKD) |
||
|
Title: Reward Processing in Autism Sponsor: National Institutes of Health (NIH) |
||
|
Title: Role of Nucleotides in Allergic Lung Disease (renewal of Role of Adenosine in Allergic Lung Disease) Sponsor: National Institutes of Health (NIH) |
||
|
Title: RPB Career Development Award Sponsor: Research to Prevent Blindness, Inc. |
||
|
Title: RPB Unrestricted Grant Sponsor: Research to Prevent Blindness, Inc. |
||
|
Title: SHARE: Translational Studies in Inflammatory Bowel Disease (Project 8) Sponsor: Leona M and Harry B Helmsley Charitable Trust |
||
|
Title: Sickle Cell Disease Patient-Centered Information System Sponsor: Patient-Centered Outcomes Research Institute (PCORI) |
||
|
Title: SIP 09-002: 4CNC: Moving Evidence into Action Sponsor: National Center for Chronic Disease Prev and Health Promo(CDC) |
||
|
Title: Strategic Timing of Antiretoviral Therapy (START or INSIGHT 101) TASK ORDER #3 Sponsor: Institute for Clinical Research |
||
|
Title: Subcontract No. CRB-UCLA1-S-10-00047-Cardiovascular, anthropometric, and skeletal effects of anti-retroviral (ARV) initiation with tenofovir/emtricitabine plus atazanavir/ritonavir (ATV/r), darunavir/ritonavir (DRV/r), or raltegravir (RTG): Metabolic Substudy of A5257 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: Substance Use Trajectories among Biracial Black Subgroups Sponsor: National Institute on Drug Abuse |
||
|
Title: T1D Exchange Type 1 Diabetes Network Ancillary Study: Residual C-peptide in Patients with Type 1 Diabetes Sponsor: Jaeb Center for Health Research Foundation |
||
|
Title: Targeting Cortical Dynamics: Rational Design of Individualized Brain Stimulation Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Childhood Obesity Policy and Comparative Effectiveness Model(COPCEM) Sponsor: University of Alabama at Birmingham |
||
|
Title: The family planning experiences and beliefs of Malawian women living with obstetric fistula: a qualitative study Sponsor: Society of Family Planning (SFP) |
||
|
Title: The Glycemia Reduction Approaches for Diabetes: A Comparative Effectiveness Study Sponsor: George Washington University |
||
|
Title: The North Carolina Network Consortium Practice-based Research and Learning Center Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: The Role of Feedback for Awareness and Correction of Asymmetric Gait Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Role of Immune Complexes and BAFF in Promoting Atherosclerosis in Lupus Sponsor: Alliance for Lupus Research (ALR) |
||
|
Title: The Role of Recycling Immune Complexes in the Breakdown of Tolerance Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Studies to Treat Or Prevent Pediatric Type 2 Diabetes--STOPP-T2D Sponsor: George Washington University |
||
|
Title: The T1D Exchange Type 1 Diabetes Network Sponsor: Jaeb Center for Health Research Inc. |
||
|
Title: The Transition To Chronic Pain in Sickle Cell Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: TMC125HIV4002 Antiretroviral Activity and Tolerability of TMC 125 in Treatment Nave Adults with HIV-1 Infection Sponsor: Janssen Global Services, LLC |
||
|
Title: To identify appropriate diabetic candidates for effective antioxidant therapy using new mouse models Sponsor: American Diabetes Association |
||
|
Title: To identify potential candidates for effective antioxidant therapy of atherosclerosis using novel mouse models Sponsor: American Heart Association - Mid Atlantic Affiliate |
||
|
Title: Tobacco Cessation Sponsor: The Office on Women's Health |
||
|
Title: Tracking Upper Extremity Adaptation and Injury in Adolescent Baseball Pitchers Sponsor: National Institutes of Health (NIH) |
||
|
Title: Training Scientists in Nutrition and Health: From Cell to Society Sponsor: Burroughs Wellcome Fund |
||
|
Title: Transdermal Pediatric Formulations for Enhancing Elimination of Radionuclides Sponsor: National Institutes of Health (NIH) |
||
|
Title: Transforming Delivery of maternal and infant care in an underresourced rural community setting Sponsor: Centers for Medicare and Medicaid Services |
||
|
Title: TRANSFORMING MEDICAL HOMES INTO MEDICAL COMMUNITIES FOR HIGH RISK PATIENTS Sponsor: National Institutes of Health (NIH) |
||
|
Title: Translational Evaluation of Cytochrome P450 Eicosanoid Metabolism as a Therapeutic Target for Cardiovascular Disease Sponsor: American Heart Association (AHA) |
||
|
Title: Ultrasonographic assessment of cervical length in non-pregnant women with and without obstetric fistula Sponsor: American College of Obstetrians and Gynocologists (ACOG) |
||
|
Title: UNC Global Women's Health Fellowship Sponsor: National Institutes of Health (NIH) |
||
|
Title: Understanding Research Policy and Practice in the Context of Biobanking Sponsor: National Institutes of Health (NIH) |
||
|
Title: University of North Caroilna AIDS Clinical Trials Unit (UNC ACTU) Sponsor: NIH National Institute of Allergy and Infectious Diseases (NIAID) |
||
|
Title: Vibration Stimulation and Inhibition of Leukotriene Activity for Prevention of Joint Contracture and Disuse Atrophy Sponsor: DOD DA Congressionally Directed Medical Research Programs |
||
|
Title: VX11-770-110 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects with Cystic Fibrosis who Have the R117H-CFTR Mutation Sponsor: Vertex Pharmaceuticals, Inc. |
||
|
Title: Within Host Selection of P. falciparum Variants by Artemisinin Combination Therapy - Adminstrative Supplement Sponsor: National Institutes of Health (NIH) |
||
| ||
|
Title: "Development of a method for in situ nanorheology of human airway mucus" Sponsor: National Institutes of Health (NIH) |
||
|
Title: "Evaluation of Breast Cancer Thermal Therapy with Optical Coherence Tomography" Sponsor: Illinois Institute of Technology |
||
|
Title: "Pharmacologic Interaction between Nanoparticle Agents and Mononuclear Phagocyte System" Sponsor: National Institutes of Health (NIH) |
||
|
Title: "Volumetric Nanorheology for Predicting Invastion in the Tumor Microenvironment" Sponsor: National Institutes of Health (NIH) |
||
|
Title: 116195 Phase I, Open-Label Study in Healthy Male Subjects Describing GSK1349572 Exposure in Blood Plasma, Seminal Fluid and Rectal Mucosal Tissue Following Single and Multiple Dosing of GSK1349572 Sponsor: GlaxoSmithKline, Inc |
||
|
Title: 11PAN01 A Phase II/III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer Sponsor: Aptium Oncology |
||
|
Title: 156-08-271 Multi-center, Open-label, Phase III Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Sponsor: Covance, Inc. |
||
|
Title: 156-10-291 A Multi-center, Longitudinal, Observational Study of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) to Establish the Rate, Characteristics, and Determinants of Disease Progression Sponsor: Covance, Inc. |
||
|
Title: 3/3-MuliSite - Omega-3 for Co-Morbid Depression & HF Treatment (OCEAN) Sponsor: National Institutes of Health (NIH) |
||
|
Title: 652-2-202 A Phase 2b Randomized, Double-Blind, Double-Dummy Trial of 100 or 200 mg Once-Daily Doses of Cenicriviroc (CVC,TBR 652) or Once-Daily EFV, Each With Open-Label FTC/TDF in HIV 1-Infected, Antiretroviral Treatment-Nave, Adult Patients with Only CCR5-Tropic Virus Sponsor: Quintiles, Inc. |
||
|
Title: A Community Focused Participatory Research Program to Evaluate COSolutions Sponsor: Innovative Educational Resources LLC |
||
|
Title: A Comparison of Long-Acting Injectable Medications for Schizophrenia - ACLAIMS Sponsor: Columbia University |
||
|
Title: A Mindfulness-based Intervention to Reduce Diabetes Risk in Prediabetic African-Americans Sponsor: National Institutes of Health (NIH) |
||
|
Title: A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants with Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP) Outcomes at 18-22 months Adjusted Age--Neonatal Research Network (NEST NEC) Sponsor: Duke University |
||
|
Title: A novel diet-Phenotype interaction affecting body weight Sponsor: Boston Children's Hosptial |
||
|
Title: A novel mechanism of coagulation in sickle cell disease Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: A Phase I, Open Label, Study in Healthy Female Subjects to Describe GSK1349572 Exposure in Blood, Cervicovaginal Fluid, and Cervical and Vaginal Tissue Following Single and Multiple Dosing of GSK1349572 Sponsor: GlaxoSmithKline, Inc |
||
|
Title: A Phase I/II Investigation of the Effect of Vorinostat (VOR) on HIV RNA expression in the Resting CD4+ T Cells of HIV-Infected Patients Receiving Stable Antiretroviral Therapy Sponsor: Merck, Sharp and Dohme Research Laboratories Corp. |
||
|
Title: A Phase IV, Open-Label Study to Characterize the First-Dose and Multiple-Dose Pharmacokinetics of Raltegravir in the Gastrointestinal Tract of Healthy Male Volunteers Sponsor: Merck Research Laboratories |
||
|
Title: A pilot study of an intervention for adolescent perinatal depression Sponsor: National Institute of Mental Health-NIH |
||
|
Title: A Randomized Controlled Trial of a Brief Educational Script on Postpartum Contraceptive Uptake Sponsor: Susan Thompson Buffett Foundation |
||
|
Title: A Randomized Feasibility Trial of a Polypill for Primary Prevention of CVD Sponsor: National Institutes of Health (NIH) |
||
|
Title: A Structured Approach to Studying and Assessing Programs for Instruction in the Responsible Conduct of Research for K Awardees-Administrative Supplement Sponsor: University of Michigan |
||
|
Title: AAV-MEDIATED GLOBAL GENE THERAPY FOR THE TREATMENT OF TAY-SACHS DISEASE Sponsor: New Hope Research Foundation |
||
|
Title: ABBO-0001 Effect of Immunomodulatory therapy with Adalimumab on Endothelial Function in patients with moderate to severe psoriasis. Sponsor: Abbott Laboratories Corp. |
||
|
Title: ABX270 A Phase II study of carboplatin, nab-paclitaxel and cetuximab for induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck - ABX270 Sponsor: Celgene |
||
|
Title: Academic - Community Partnership to Reduce Health Disparities in Infant Mortality Sponsor: National Institutes of Health (NIH) |
||
|
Title: Accelerating Progress in Addressing Social Determinants of Health Equity in MCH Sponsor: National Institutes of Health (NIH) |
||
|
Title: ACCORDION: Action to Control Cardiovascular Risk in Diabetes Follow-On Sponsor: Wake Forest University |
||
|
Title: Adenosine receptors as therapeutic targets for chronic rhinosinusitis Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Adult Cystic Fibrosis Center Grant (NC-106/76-University of North Carolina at Chapel Hill) Sponsor: Cystic Fibrosis Foundation |
||
|
Title: Aerobic glycolysis regulates apoptosis in neurogenesis and medulloblastoma Sponsor: National Institutes of Health (NIH) |
||
|
Title: AIDS Clinical Trials Group Network ("ACTG") Sponsor: Social and Scientific Systems, Inc |
||
|
Title: AIDS Clinical Trials Group Network ("ACTG") Protocol 5254 supplement
BRS-ACURE-S-11-000080-001979 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: Altered Hepatic Disposition of Anionic Drugs - Mechanisms Sponsor: National Institutes of Health (NIH) |
||
|
Title: AN ERYTHROPOIETIN-MIMETIC PEPTIDE (pHBSP) FOR TREATMENT OF TBI Sponsor: Baylor College of Medicine |
||
|
Title: An Innovative Approach to Improving Chronic Kidney Disease Outcomes Sponsor: National Institutes of Health (NIH) |
||
|
Title: Ancestry As A Determinant Of Outcomes In Acute Lymphoblastic Leukemia -- Exploring The Pharmacogenomic Basis For Altered Chemotherapy-Induced Cytotoxicity Phenotypes Sponsor: American Society of Hematology |
||
|
Title: Ancestry as a Determinant of Outcomes in Acute Lymphoblastic Leukemia-th Pharmacogenomic Basis for Altered Chemotherapy-Induced Cytotoxicity Phenotypes Sponsor: US Department of Defense |
||
|
Title: API-CL-016 A multi-center, open-label, surgical surveillance trial to evaluate the safety and efficacy of a shortened infusion time of intravenous ibuprofen Sponsor: Cumberland Pharmaceuticals, Inc. |
||
|
Title: Arachidonic acid metabolism in vascular inflammation and cardiovascular disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: ARRA - Southern Piedmont Beacon Community Project Sponsor: Southern Piedmont Community Care Plan |
||
|
Title: Assessing tumor angiogenesis and therapeutic response with a targeted MRI agent Sponsor: Washington University School of Medicine |
||
|
Title: Assessment of SPIO-RL Platelets for Contrasting Partially-Occlusive Thrombi Sponsor: National Institutes of Health (NIH) |
||
|
Title: Autism in Older Adults: A Pilot, Descriptive Study Sponsor: National Institutes of Health (NIH) |
||
|
Title: Beta2 Adrenergic Receptor Agonists in the Treatment of PD Sponsor: Michael J. Fox Foundation |
||
|
Title: BK Virus: Its role in BLL Causation and Salivary Gland Cell Deregulation Sponsor: National Institutes of Health (NIH) |
||
|
Title: BRS-ACURE-S-11-000080-001304 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: BRS-ACURE-S-11-000080-001310 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: BSTE-0510 Clinical Evaluation of the Accuracy of the PIMA TM CD4 Test for Enumeration of CD4+ T-Cell Counts Sponsor: Alere Scarborough, Inc. |
||
|
Title: C13008 A Phase 3, Open-label Study to Determine the Long-Term Safety and Efficacy of Vedolizumab (MLN0002) in Patients with Ulcerative Colitis and Crohn's Disease Sponsor: Quintiles, Inc. |
||
|
Title: C13011 A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients with Moderate to Severe Crohn's Disease Sponsor: Millennium Pharmaceuticals, Inc. |
||
|
Title: C14011 A Multicenter, Phase 1-2 Study of MLN8237, an Oral Aurora A Kinase Inhibitor, in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab and Vincristine Sponsor: Millennium Pharmaceuticals, Inc. |
||
|
Title: C33457/3075 An Open-Label Long Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients with Systemic Lupus Erythematosus Sponsor: Cephalon, Inc. |
||
|
Title: CAMN107X220 A 24 week, randomized, double blind, multicenter, placebo controlled, efficacy, safety, tolerability and PK trial of Nilotinib (Tasigna, AMN107) in Pulmonary Arterial Hypertension (PAH) Sponsor: Novartis Pharmaceuticals Corporation |
||
|
Title: CAREER: "Optical Coherence Microrheology and Tomography of Tissue-Scale Dynamics" Sponsor: National Science Foundation - Research (NSF) |
||
|
Title: Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II) - Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II)- Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: Carolina Community Network Center to Reduce Cancer Health Disparities - Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: CCX114151 A Randomized Double-blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately to Severely Active Crohn's Disease. Sponsor: Robarts Research Institute |
||
|
Title: CCX114157 A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn's Disease. Sponsor: Robarts Research Institute |
||
|
Title: CCX114644 An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn's Disease. Sponsor: Robarts Research Institute |
||
|
Title: Center of Excellence for Training and Research Translation: Evaluation Supplement Sponsor: Deloitte Consulting LLP |
||
|
Title: Characterizing the Effects of a novel B-arrestin Biased Dopamine Ligand Sponsor: National Institutes of Health (NIH) |
||
|
Title: Chronic Stress in Adolescent-Young Adult (AYA) Cancer Survivors and Their Siblings Sponsor: National Institute of Nursing Research |
||
|
Title: Chronic Stress in Adolescent-Young Adult Cancer Survivors and Their Siblings Sponsor: National Institutes of Health (NIH) |
||
|
Title: Cigarette Smoke and Susceptibility to Influenza Infection Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: Cigarette smoke, allergic inflammation & NK cells Sponsor: Flight Attendant Medical Research Institute, Inc. |
||
|
Title: Cigarette Smoking and the Microbiota in Experimental IBD Sponsor: Crohn's and Colitis Foundation of America, Inc. |
||
|
Title: Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients with Schizophrenia Stabilized on Lurasidone Sponsor: Research Foundation for Mental Hygiene, Inc |
||
|
Title: CMX001-350 Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses Sponsor: Chimerix, Inc |
||
|
Title: CMX157 Sponsor: Chimerix, Inc |
||
|
Title: CNTO328MCD2002 An Open-label, Multicenter Study to Evaluate the Safety of Long-term Treatment with Siltuximab in Subjects with Multicentric Castleman's Disease Sponsor: Centocor, Inc. |
||
|
Title: Comparative Effectiveness of Management Options for Localized Prostate Cancer Parallel study to include patients treated with Cyberknife radiation therapy Sponsor: Accuray Incorporated |
||
|
Title: Comparison of the Relative Oral Bioavailability of Tolvaptan Administered via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact Sponsor: Otsuka America Pharmaceutical, Inc |
||
|
Title: Connect to Fitness CP: A Web - Supported Community Fitness Program for Adults with Cerebral Palsy Sponsor: National Institute on Disability and Rehabilation Research |
||
|
Title: Core B: Chavie 012 UNC Site Sponsor: Duke University |
||
|
Title: CPI-CL-015 A multi-center, open-label, surveillance trial to evaluate the safety and efficacy of a shortened infusion time of intravenous ibuprofen Sponsor: Cumberland Pharmaceuticals, Inc. |
||
|
Title: CROSS-SPECIES INVESTIGATION OF THE IMPACT OF OBESITY ON OVARIAN CANCER PATHOGENESIS Sponsor: National Institutes of Health (NIH) |
||
|
Title: Cytochrome P450 Eicosanoids, Inflammation and Outcomes in Coronary Artery Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: dcr-0742 A Randomized Parallel Study Comparing the Interproximal Plaque and Gingivitis Effects of Three Interdental Cleaning Modalities Sponsor: Philips Oral Healthcare, Inc. |
||
|
Title: DEFEND-1: Durable-Response Therapy Evaluation For Early- or New-Onset Type 1 Diabetes Sponsor: Tolerx, Inc. |
||
|
Title: Determine the effect of insulin-like growth factor binding protein-2 (IGFBP-2) on prostate cancer cell grwoth and tumor progression Sponsor: US Department of Defense |
||
|
Title: Development and testing of a norovirus GII.4 Hunan Challenge Inocula Sponsor: NC Biotechnology Center |
||
|
Title: Development of a Method for In Situ Nanorheology of Human Airway Mucus Sponsor: National Institutes of Health (NIH) |
||
|
Title: Development of a Porcine Model of Duchenne Muscular Dystrophy Sponsor: Texas A and M University |
||
|
Title: Development of an osteoporosis screening protocol for postmenopausal women Sponsor: National Institute of Arthritis Musculoskeletal Skin Disease |
||
|
Title: Development of Optimized AAV Vectors for Intra-CSF Administration in Rett mice Sponsor: International Rett Syndrome Foundation |
||
|
Title: Development of Web Triage as a Critical Patient Portal Function Sponsor: Keona Health |
||
|
Title: Dietary interventions in episodic migraine: Clinical and metabolic effects of lowering tissue content and inhibiting metabolism of arachidonic acid Sponsor: National Institutes of Health (NIH) |
||
|
Title: Differential regulation of autoimmune arthritis by monocyte subsets Sponsor: National Institutes of Health (NIH) |
||
|
Title: Directed Evolution of Targeted AAV Gene Delivery Vectors to Increase the Efficacy and Reduce the Invasiveness of ALS Gene Therapy Sponsor: Congressionally Directed Medical Research Programs (CDMRP) |
||
|
Title: Dissecting the Human Antibody Response to Dengue Virus Sponsor: National Institutes of Health (NIH) |
||
|
Title: Dose-finding Study of Chromium Picolinate in Binge Eating Disorder Sponsor: National Institutes of Health (NIH) |
||
|
Title: Drug Induced Liver Injury Network (DILIN) Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: DU176b-C-U301 A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of DU-176b Versus Warfarin In Subjects with Atrial Fibrillation - Effective aNticoaGulation with Factor xA Next GEnerationin Atrial Fibrillation (ENGAGE AF - TIMI 48) Sponsor: Daiichi Sankyo Pharma |
||
|
Title: DU176b-C-U301 A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of DU-176b Versus Warfarin In Subjects with Atrial Fibrillation - Effective aNticoaGulation with Factor xA Next GEnerationin Atrial Fibrillation (ENGAGE AF - TIMI 48) Sponsor: Quintiles, Inc. |
||
|
Title: Durable-Response Therapy Evaluation for Early-or New-Onset Type 1 Diabetes (DEFEND-1) AND DEFEND-1 Long Term Follow Up Sponsor: Tolerx, Inc. |
||
|
Title: Dynamics of Obesity Intervention Adoption, Implementation and Maintenance Sponsor: Virginia Polytechnic Institute |
||
|
Title: Effect of Malaria Parasite Diversity and Dynamics on Circumsporozoite Vaccines Sponsor: National Institutes of Health (NIH) |
||
|
Title: Effect of topiramate on severity of inflammatory bowel disease: exploratory study of a potential novel therapeutic agent using administrative claims data. Sponsor: Foundation for Clinical Research |
||
|
Title: Effectiveness of antibiotics in immediate placement and loading of dental implants Sponsor: American Academy of Implant Dentistry Research Foundation |
||
|
Title: Effects of Care Coordination Services on Maternal and Child Health Outcomes Sponsor: Pennsylvania State University |
||
|
Title: Efficacy and Safety of High-Dose Baclofen for Alcohol Dependence Sponsor: National Institutes of Health (NIH) |
||
|
Title: Elucidating Links Between ADHD Symptoms & Tobacco/Alcohol Use Trajectories: Supplement Sponsor: Duke University |
||
|
Title: Enabling safe access to peripheral lung nodules using concentric tube needles Sponsor: National Institutes of Health (NIH) |
||
|
Title: Endothelial Dysfunction in the Pathogenesis of Sickle Cell Nephropathy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Engaging children in communication and decision-making to improve asthma care Sponsor: PCORI |
||
|
Title: Enhanced Registries for Quality Improvement and Comparative Effectiveness Research Sponsor: Children's Hospital Medical Center of Cincinnati |
||
|
Title: Enhancing Group Identity May Improve Effectiveness of Diabetes Self-Management Education Sponsor: Advanced TeleCare, LLC |
||
|
Title: Enhancing HIV screening Among Primary care physicians in the Southeast Sponsor: National Institutes of Health (NIH) |
||
|
Title: Ensuring Research Integrity in Community-Based Participatory Research Sponsor: National Institute of Environmental Health Sciences |
||
|
Title: Enumerating the Community Burden of Heart Failure Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome Sponsor: National Institutes of Health (NIH) |
||
|
Title: Error Based Learning for Restoring Gait Symmetry Post-Stroke Sponsor: National Institutes of Health (NIH) |
||
|
Title: Evaluation of Soluble Epoxide Hydrolase as a Secondary Prevention Strategy for Patients with Ischemic Heart Disease Sponsor: Gilead Palo Alto, Inc (merged with CV Therapeutics,Inc) |
||
|
Title: Experimental Study of Patient Information Prototypes Task Order #8 Sponsor: Research Triangle Institute |
||
|
Title: Faith, Farming, the Future: A church-based program addressing health disparities Sponsor: National Institutes of Health (NIH) |
||
|
Title: Family Management of Feeding When at Risk for Tube Placement Sponsor: National Institutes of Health (NIH) |
||
|
Title: Family Management of Feeding When at Risk for Tube Placement Sponsor: National Institute of Nursing Research |
||
|
Title: fcMRI in Infants at High Risk for Autism Sponsor: Washington University @ St. Louis, Mo. |
||
|
Title: FMRI Study of Sweet Perception and Reward in Antipsychotic-Induced Weight Gain Sponsor: National Institutes of Health (NIH) |
||
|
Title: Focal Segmental Glomerulosclerosis Clinical Trial Sponsor: University of Michigan |
||
|
Title: Gene Expression of TGFB1 and IL-8 in Cystic Fibrosis Lung Disease Sponsor: Cystic Fibrosis Foundation |
||
|
Title: Gene Targets for IVH Sponsor: Yale University |
||
|
Title: Genetic and epigenetic consequences of adolescent feeding behavior: Implications for the development of eating disorders Sponsor: National Alliance Res on Schizophrenia and Depression (NARSAD) |
||
|
Title: Genetic Etiology of Cancer Drug Response Sponsor: North Carolina State University |
||
|
Title: Genetic Factors and Molecular Metrics of Vaccine Efficacy via the Deconvolution of Memory B cell, Humoral and T Cell Responses Sponsor: University of Texas at Austin |
||
|
Title: GS-US-205-0162 Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients with Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas aeruginosa (PA) Aztreonam Lysine for Pseudomonas Infection Eradication (ALPINE) Sponsor: Gilead Sciences, Inc. (merged with CV Therapeutics,Inc) |
||
|
Title: GS-US-300-0140 A Randomized, Multicenter Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension. Sponsor: Gilead Sciences, Inc. (merged with CV Therapeutics,Inc) |
||
|
Title: Gut Peptides and Gastric Emptying in Patients with Postprandial Distress Symptoms Sponsor: National Institutes of Health (NIH) |
||
|
Title: H7T-MC-TACX An Open-Label, Dose-Ranging Study of Prasugrel in Pediatric Patients with Sickle Cell Disease Sponsor: Eli Lilly and Co. |
||
|
Title: H7T-MC-TAEK(a) A Double Blind, Randomized Multicenter Study of Prasugrel Compared to Placebo in Adult Patients with Sickle Cell Disease Sponsor: Parexel |
||
|
Title: H9B-MC-BCDT A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) Sponsor: Parexel |
||
|
Title: Health Literacy and Management of Cardiovascular Risk among HIV-infected Adults Sponsor: National Institutes of Health (NIH) |
||
|
Title: Healthy, Native North Carolinians Sponsor: North Carolina Commission on Indian Affairs |
||
|
Title: Hemofiltration Device for Hyperphosphatemia Treatment Sponsor: North Carolina State University |
||
|
Title: HIV Latency, Epigenetics, and Therapeutics Sponsor: National Institutes of Health (NIH) |
||
|
Title: HIV Tropism, Persistence, Inflammation and Neurocognition in Therapy Initiation Sponsor: National Institute of Mental Health-NIH |
||
|
Title: HIV, cART and aging effects on p16 expression 2011 CFAR Supplement Opportunity-HIV and Aging Sponsor: National Institutes of Health (NIH) |
||
|
Title: Host Immunity and the Plasmodium vivax Genome: Identifying Targets of Immunity by Genomic Signatures of Selection Sponsor: Burroughs Wellcome Fund |
||
|
Title: HQP 1001-SCD-006 A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects with Sickle Cell Disease Sponsor: HemaQuest Pharmaceuticals, Inc. |
||
|
Title: Human Cytochrome P450 4F Enzymes and Drug Interactions Sponsor: University of Kansas |
||
|
Title: Identification of Small molecule heme oxygenase-1 inducers as therapeautics for IBD Sponsor: US Department of Defense |
||
|
Title: Identifying potential targets in diabetic nephropathy using genetic models Sponsor: Juvenile Diabetes Research Foundation |
||
|
Title: Immediate placement and loading of dental implants into infected sites with and without antibiotic prophylaxis: an exploratory study Sponsor: American College of Prosthodontists |
||
|
Title: Immediate postpartum vs. 4-8 week postpartum LNG-IUS use and breastfeeding: A randomized clinical trial Sponsor: Society of Family Planning |
||
|
Title: Immunity Against Ovarian Cancer from Acute Inflammatory Events Involving Mucin-Expressing Tissue Sponsor: US Department of Defense |
||
|
Title: Impact of Maternal High Fat Diet on the Development of Reward-Related Disorders in Adolescence Sponsor: National Institutes of Health (NIH) |
||
|
Title: Impact of Physical Activity on Achieving Pregnancy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Impact of Social Factors on the Effectiveness of Preconceptional PTB Program Sponsor: National Institutes of Health (NIH) |
||
|
Title: Impacting agriculture science education with experiential, computer aided and social network learning methodologies Sponsor: East Carolina University |
||
|
Title: Implanted bioreactor to direct development of engineered cartilage in mice Sponsor: Plastic Surgery Education Foundation |
||
|
Title: Implementation of a COPD Care Bundle to Improve Quality of Care in Acute COPD Sponsor: National Institutes of Health (NIH) |
||
|
Title: Improving chemoradiotherapy: novel approaches from nanomedicine Sponsor: American Cancer Society |
||
|
Title: Improving chemoradiotherapy: novel approaches using nanomedicine Sponsor: National Institutes of Health (NIH) |
||
|
Title: Improving Colon Cancer Screening in Latinos with Limited English Proficiency Sponsor: National Cancer Institute |
||
|
Title: Improving Colorectal Cancer Screening for Latinos in Primary Care Sponsor: American Cancer Society |
||
|
Title: Improving the Impact of Mental Health Courts Sponsor: National Institute of Mental Health-NIH |
||
|
Title: In vivo Progesterone Dose Manipulation and Progesterone Receptor ChIP-Seq to Uncover Markers of Normal and Abnormal Endometrial Function. Sponsor: EMD Serono, Inc. |
||
|
Title: Incorporating Comparative Effectiveness Research Tools to Examine the Effect of a Reimbursement Policy Change on Local Public Health Service Outcomes Sponsor: Robert Wood Johnson Foundation |
||
|
Title: Increasing Colorectal Cancer Screening Rates in Community Health Centers Sponsor: National Institutes of Health (NIH) |
||
|
Title: Increasing Healthy Food Access for the Poor through Local Business Opportunities Sponsor: Lenoir County Cooperative Extension |
||
|
Title: Inducing Remission in New Onset T1Dm with Alefacept (Amevive) Sponsor: University of California at San Francisco |
||
|
Title: Inflammatory Effect of Enteric Bacterial-Mediated Intestinal Permeability Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: ING111762 A Phase III Randomized, Double-Blind Study of the Safety and Efficacy of GSK 1349572 50 mg Once Daily Versus Raltegravir 400 mg Twice Daily, Both Administered with an Investigator-Selected Background Regimen over 48 weeks in HIV-1 Infected, Integrase Inhibitor-Naive,
Antiretroviral Therapy-Experienced Adults Sponsor: GlaxoSmithKline, Inc |
||
|
Title: ING112574 A Phase III study to demonstrate the antiviral activity and safety of dolutegravir in HIV-1-infected adult subjects with treatment failure on an integrase inhibitor containing regimen Sponsor: GlaxoSmithKline, Inc |
||
|
Title: ING114467 A Phase III, randomized, double-blind study of the safety and efficacy of GSK1349572 plus abacavir/lamivudine fixed-dose combination therapy administered once daily compared to Atripla over 96 weeks in HIV-1 infected antiretroviral therapy naive adult subjects Sponsor: GlaxoSmithKline, Inc |
||
|
Title: ING114915 A Phase IIIb, randomized, open-label study of the safety and efficacy of GSK1349572 (dolutegravir, DTG) 50 mg once daily compared to darunavir/ritonavir (DRV/r) 800 mg/100 mg once daily each administered with fixed-dose dual nucleoside reverse transcriptase inhibitor therapy over 96 weeks in HIV-1 infected antiretroviral nave adult subjects Sponsor: GlaxoSmithKline, Inc |
||
|
Title: Integrating Prenatal and Infant Oral Health Care Sponsor: National Children's Oral Health Foundation |
||
|
Title: Interactive Mechanisms in Sickle Cell Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Investigation of the Gene Therapy Approaches for the Treatment of Giant Neuropathy Sponsor: Hannah's Hope Fund |
||
|
Title: Investing in Women to Improve Self-Sufficiency & Health Thru TANF Sponsor: National Institute of Nursing Research |
||
|
Title: IRC 001: A Pilot Study for the collection of Anit-Influenza A H1N1 Plasma Sponsor: Social and Scientific Systems, Inc |
||
|
Title: Isoflavones (genistein, daidzein and glycetin), Black Cohosh (Cimicifuga racemosa) and the GPR30 Estrogen Receptor Sponsor: Endocrine Fellows Foundation |
||
|
Title: Jak-Stat signaling: a driving force and novel target for medulloblastoma Sponsor: St. Baldrick's Foundation |
||
|
Title: LEADER: Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events Sponsor: Novo Nordisk Pharmaceuticals, Inc. |
||
|
Title: Leukemia Stem Cell Antigen Discovery Using Advanced Genomic and Proteomic Methods Sponsor: National Institutes of Health (NIH) |
||
|
Title: Longitudinal relationships among inflammation, obesity, and CV risk in children Sponsor: National Institutes of Health (NIH) |
||
|
Title: Low Intensity Exercise and Cardiovascular Health for Older Women Sponsor: American Heart Association |
||
|
Title: LX4211 A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Gropu Study to Evaluate teh Safety and Efficacy of LX4211 in Combination with Metformin in Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Monotherapy. Sponsor: Lexicon Pharmaceuticals, Inc. |
||
|
Title: Magnetomotive Ultrasound for Monitoring Internal Bleeding using Magnetically-Labeled RL Platelets Sponsor: Office of Naval Research |
||
|
Title: MAH-11-0059 A Randomized Parallel Method Development Study Comparing Clinical to Subclinical Effects from Oral Cleaning Modalities Sponsor: Philips Oral Healthcare, Inc. |
||
|
Title: Mapping Multidimensional Illness Trajectories of Patients with End-Stage Kidney Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: MCP5 as key mediator of TGFbeta signaling in joint maintenance and osteoarthritis Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mechanisms of Decline in Cerebral Oxygen Reserve and Cognitive Decline in Elders Sponsor: National Institutes of Health (NIH) |
||
|
Title: Medtronic Neuromodulation Pain Fellowship Program Policy 2011-2012 Sponsor: Medtronic, Inc |
||
|
Title: Mentoring in community influences on CVD risk Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: Merck Program for Assistance with Transitions from Hospital to Home (PATHH) Sponsor: Merck, Sharp and Dohme Research Laboratories Corp. |
||
|
Title: Metabolomic Profiling to Assess Disease Severity in Cystic Fibrosis Sponsor: Cystic Fibrosis Foundation Therapeutics, Inc. |
||
|
Title: Metformin As A Novel Chemotherapeutic Strategy for the Treatment of Endometrial Cancer Sponsor: National Institutes of Health (NIH) |
||
|
Title: Metformin for the Treatment of Endometrial Hyperplasia Sponsor: American Society of Clinical Oncology |
||
|
Title: MEthotrexate Response In Treatment of UC - MERIT-UC Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: Microbial biomarkers for postoperative recurrence of ileal Crohn's disease Sponsor: Washington University @ St. Louis, Mo. |
||
|
Title: Microbial Biomarkers for Postoperative Recurrence of Ileal Crohn's Disease Sponsor: University of New York at Stony Brook |
||
|
Title: Microfludic Nitric Oxide Sensor as Wound Healing Prognostic Tool Sponsor: Clinical Sensors, Inc |
||
|
Title: Mind-Body Skills Training to Enhance Pain Management in Sickle Cell Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mindfullness: a novel approach for the management of diabetes-related distress Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mitigating the pubic health impact of osteoarthritis Sponsor: National Institutes of Health (NIH) |
||
|
Title: Molecular mechanisms and biomarkers of a candidate Angelman syndrome therapeutic Sponsor: Angelman Syndrome Foundation |
||
|
Title: Mood, mother and infant: The psychobiology of impaired dyadic development Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mpex 207 A Phase 3, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate The Efficacy and Safety of MP-376 (Levofloxacin Inhalation Solution Aeroquin) in Stable Cystic Febrosis Patients Sponsor: Mpex Pharmaceuticals |
||
|
Title: MRP4 Structural Features and Polymorphisms in Drug-Induced Liver Injury Sponsor: National Institutes of Health (NIH) |
||
|
Title: Multiscale Modeling of Inherited Arrhythmias Sponsor: State University of New York (SUNY) |
||
|
Title: NAI114373 A Phase III international, randomized, double-blind, double-dummy study to evaluate the efficacy and safety of 300 mg or 600 mg of intravenous zanamivir twice daily compared to 75 mg of oral oseltamivir twice daily in the treatment of hospitalized adults and adolescents with influenza Sponsor: GlaxoSmithKline, Inc |
||
|
Title: Nanoparticle co-delivery of small interference RNA and estramustine for the treatment of advanced prostate cancer Sponsor: US Department of Defense |
||
|
Title: Nanoparticle Etoposide Phosphate (NanoVP16) As a Novel Anticancer Drug Sponsor: Qualiber, Inc. |
||
|
Title: NC GENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing Sponsor: National Human Genome Research Institute (NHGRI) |
||
|
Title: Neisseria gonorrhoeae peptidoglycan signaling in inflammation and adaptive immunity Sponsor: National Institutes of Health (NIH) |
||
|
Title: Neoadjuvant Pazopanib: A Phase II Study to Evaluate the Effect on Disease esponse and Recurrence and to Establish Predictive Biomarkers of Drug Activity in Renal Cell Carcinoma Sponsor: GlaxoSmithKline, Inc |
||
|
Title: Neonatal Neurobehavior and Outcomes in Very Preterm Infants (NOVI) Sponsor: Brown University |
||
|
Title: Neurobiology of Adolescent Stress, Resilience, and Schizophrenia Vulnerability Sponsor: National Institutes of Health (NIH) |
||
|
Title: Next Generation Pre-exposure Prophylaxis Sponsor: National Institutes of Health (NIH) |
||
|
Title: NICHD Neonatal Research Network--Optimizing Cooling Strategies at <6 hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy (HIE) Sponsor: Duke University |
||
|
Title: NIH NHLBI Contract HHSN268201000048C-N01-HV-08-238 GenTAC SOW for UNC-BSP Sponsor: Research Triangle Institute |
||
|
Title: NN9068-3697 Dual Action of Liraglutide and insulin degludec in type 2 diabetes. A trial comparing the efficacy and safety of insulin degludec/liraglutide, insulin degludec and liraglutide in subjects with type 2 diabetes. A 26 week randomized, parallel three-arm, open-label, multi-centre, multinational treat-to-target trial comparing fixed ratio combination of insulin degludec and liraglutide versus insulin degludec or liraglutide alone, in subjects with type 2 diabetes treated with 1-2 oral anti-diabetic drugs (OADs). Sponsor: Novo Nordisk Pharmaceuticals, Inc. |
||
|
Title: Non-invasive zoonotic pathogen exposure and outcome biomarkers with follow-up in livestock workers and household members Sponsor: Centers for Disease Control and Prevention (CDC) |
||
|
Title: North Carolina Green Cart Project Sponsor: Blue Cross Blue Shield of North Carolina Foundation |
||
|
Title: Obesity Exposure Across the Lifespan on Ovarian Cancer Pathogenesis (PQ1) Sponsor: National Institutes of Health (NIH) |
||
|
Title: Obesity, Metformin and Endometrial Cancer Sponsor: Damon Runyon Cancer Research Foundation |
||
|
Title: Optimizing Cooling Strategies Less Than 6 hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy (HIE) Sponsor: Duke University |
||
|
Title: Optimizing HPV Vaccination: parents, providers and pre-teen boys Sponsor: National Institutes of Health (NIH) |
||
|
Title: Optimizing Oral Pediatric HIV Vaccines to Prevent Breast Milk Transmission Sponsor: National Institutes of Health (NIH) |
||
|
Title: Osmotic Signaling in Chondrocyte Aging and Osteoarthritis Sponsor: National Institutes of Health (NIH) |
||
|
Title: P-0020 A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Tryton Side Branch Stent used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation Sponsor: Tryton Medical, Inc. |
||
|
Title: P7977-0422 Multi-Center, Placebo-Controlled, Dose Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics following Oral Administration of PSI-7977 in Combination with Pegylated Interferon and Ribavirin in Treatment-Naive Patients with Chronic HCV Genotype 1, and an Open Label Assessment of PSI-7977 in Patients with HCV Genotypes 2 and 3. Sponsor: Pharmasset, Inc |
||
|
Title: PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases Sponsor: National Institutes of Health (NIH) |
||
|
Title: Partnering to Improve the Health of Lehigh Valley through Building Capacity in Community-Based Participatory Research (CBPR) Sponsor: Lehigh Valley Health Network |
||
|
Title: Perinatal and Maternal SA Initiative Sponsor: Governor's Institute on Alcohol and Substance Abuse... |
||
|
Title: Periodantal Disease as a Casual Risk Factor for Gestational Diabetes Mellitus Sponsor: Tulane University |
||
|
Title: Persistent COMT-dependent Pain: Role of -adrenergic Receptors (Supplement) Sponsor: National Institutes of Health (NIH) |
||
|
Title: Phenotypes of diabetic kidney disease and the relationship to retinal pathology Sponsor: National Institutes of Health (NIH) |
||
|
Title: Philadelphia Roadmap to Women's Health Equity Project Sponsor: Kresge Foundation |
||
|
Title: Physical Activity and Conception Among Healthy Women Sponsor: National Institutes of Health (NIH) |
||
|
Title: Pilot Study of the Relationship of Ambient Copeptin to the Aquarectic Effects of Tolvaptan in Patients with Heart Failure Sponsor: Otsuka America Pharmaceutical, Inc |
||
|
Title: Plasma exchange and steroid dosing in the treatment of anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis: an international randomized controlled trial Sponsor: Boston University |
||
|
Title: Polyfluoroalkyl Compounds and Neurodevelopment Sponsor: National Institutes of Health (NIH) |
||
|
Title: Pre-clinical and Clinical Investigation of the Impact of Obesity on Ovarian Cancer Pathogenesis Sponsor: US Department of Defense |
||
|
Title: Preliminary Effectiveness Analysis of Universal Rotavirus Immunization, Nicaragua Sponsor: National Institutes of Health (NIH) |
||
|
Title: PrEP for HIV: LinkingAntiretroviral PK/PD to Identify Optimal Dosing Strategies Sponsor: National Institutes of Health (NIH) |
||
|
Title: PREVENT PAIN: Propranolol to reduce the development of persistent pain. Sponsor: Mayday Fund |
||
|
Title: Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues Sponsor: National Institutes of Health (NIH) |
||
|
Title: Profiling factors that affect PK/PD of nanoparticles in clinical systems Sponsor: National Institutes of Health (NIH) |
||
|
Title: Prospective Evaluation of Radiation-Induced Retinal Changes in Humans Sponsor: ASCO Cancer Foundation |
||
|
Title: PTD- Peptide Therapy to Treat Parkinson's Disease Sponsor: TheraLogics |
||
|
Title: Quality Care for Older Adults: Medication Management in Medical Homes Sponsor: National Institutes of Health (NIH) |
||
|
Title: Racial disparities in home health care: What are the contributing factors? Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians Working in Long-Term Care Facilities Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Regulation of the physiologic and pathologic activation of the NLRP3-inflammasome Sponsor: National Institutes of Health (NIH) |
||
|
Title: Regulation of the Physiologic and Pathologic Activation of the NLRP3-Inflammasome-Research Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: REsearch of Beta Blocker Utilization In LongituDinal Database in Heart Failure in Patients Hospitalized for Acute Heart Failure (REBUILD - AHF) Sponsor: Critical Care Diagnostics, Inc. |
||
|
Title: Restoration of mutant CFTR stability and function Sponsor: National Institutes of Health (NIH) |
||
|
Title: Roadmap for in vivo retinal repair Sponsor: National Institutes of Health (NIH) |
||
|
Title: Role of NF-kB in Dopiminergic Neuoron Development Sponsor: National Institutes of Health (NIH) |
||
|
Title: RQAD001L2202 An open-label, multicenter phase II study to compare the efficacy and safety of RAD001 as first-line followed by second-line sunitinib versus sunitinib as first-line followed by second-line RAD001 in the treatment of patients with metastatic renal cell carcinoma Sponsor: Novartis Pharmaceuticals Corporation |
||
|
Title: SIP 09-004: Center for Excellence for Training and Research Translation Sponsor: National Center for Chronic Disease Prev and Health Promo(CDC) |
||
|
Title: Social-ecological approach to address breastfeeding disparities through community Sponsor: National Institutes of Health (NIH) |
||
|
Title: Splice Variant Protein Discovery by Parallel RACE and Mass Spectrometry (PQ 11) Sponsor: National Institutes of Health (NIH) |
||
|
Title: SPP100A2368 A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the 6 months efficacy and safety of aliskiren therapy on top of standard therapy, on morbidity and mortality when initiated early after hospitalization for acute decompensated heart failure (ASTRO) Sponsor: Novartis Pharmaceuticals Corporation |
||
|
Title: Strategic timing of Anti-Retroviral Treatment (START OR INSIGHT 101) Sponsor: Institute for Clinical Research, Inc. |
||
|
Title: Subcontract for "A System for Automatic Segmentation of Male Pelvis Structures from CT Images" Sponsor: Morphormics, Inc |
||
|
Title: Susceptibility and Protective Immunity to Noroviruses Sponsor: National Institutes of Health (NIH) |
||
|
Title: Sustainable Comprehensive Tobacco Cessation and Prevention Clinical Program for Low Socio-economic Status Women of Childbearing Age Sponsor: United States Dept of Health and Human Services |
||
|
Title: Synereca Sponsored Research Amendment Sponsor: Synereca Pharmaceuticals, Inc |
||
|
Title: Tailored Web-Based Intervention for Cancer Patients and Their Family Caregivers - Subcontract Sponsor: University of Michigan |
||
|
Title: Targeting CC-Chemokine Receptor 7 for the prevention of graft-versus-host disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Targeting Leukemia Stem Cell - Specific Minor Histocompatibility Antigens Sponsor: Leukemia and Lymphoma Society of America |
||
|
Title: Targetting complement activation in ANCA vasculitis Sponsor: Alexion Pharmaceuticals, Inc. |
||
|
Title: Taste Texting: A Pre-Order System for Fresh and Healthy High School Lunch Sponsor: Cornell University |
||
|
Title: Technical Advisor on Sexually Transmitted Infections, Sexual Health, and HIV Prevention Sponsor: Wits Health Consortium |
||
|
Title: Temporal Analysis Of Nitric Oxide As Potential Sepsis Biomarker Sponsor: National Institutes of Health (NIH) |
||
|
Title: Temporal analysis of nitric oxide as potential sepsis biomarker Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Assessment of Military Multitasking Performance Sponsor: Sister Kenny Research Institute |
||
|
Title: The effects of NRF2 modulation on oxidant-induced airway inflammation Sponsor: American Lung Association |
||
|
Title: The Effects of Pharmacological Intervention on Blood Perfusion in Hypoxic Animal Model Sponsor: Duke University Medical Center |
||
|
Title: The Glycemia Reduction Approaches for Diabetes: A Comparative Effectiveness Study Sponsor: National Institutes of Health (NIH) |
||
|
Title: The impact of intensive livestock production on the disease ecology of antibiotic resistant staphylococcus Sponsor: National Science Foundation - Research (NSF) |
||
|
Title: The Impact of Obesity on Ovarian Cancer Pathogenesis and Treatment Sponsor: American Cancer Society |
||
|
Title: The Impact of Obesity on Ovarian Cancer Pathogenesis and Treatment Sponsor: Sidney Kimmel Foundation for Cancer Research |
||
|
Title: The Intestinal Microbiota and Gastrointestinal Physiological Functions Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: The Quick CHEF (Cost-efficient, Healthy Easy Food) Program (Year 2) Sponsor: North Carolina Division of Social Services |
||
|
Title: The Role of Feedback for Detection and Correction of Asymmetric Gait Sponsor: National Institutes of Health (NIH) |
||
|
Title: The role of IGFBP-2 in adipogenesis Sponsor: American Heart Association - Mid Atlantic Affiliate |
||
|
Title: Therapy of Drug Resistant Melanoma Sponsor: Pennsylvania State University |
||
|
Title: Thrombosis and Hemostasis Centers Research and Prevention Network Sponsor: Centers for Disease Control and Prevention (CDC) |
||
|
Title: Tissue Engineered Hyaline Cartilage Constructs for Airway Reconstruction Sponsor: American Society of Pediatric Otolaryngology |
||
|
Title: TMC114HIV3015 A single arm, open label study to assess the pharmacokinetics of darunavir/ritonavir and/or etravine in HIV-1 infected pregnant women Sponsor: Tibotec Pharmaceuticals Ltd |
||
|
Title: To identify appropriate candidates for effective antioxidant therapy using new mouse models Sponsor: American Diabetes Association |
||
|
Title: Towards therapy-induced lethal HIV mutagenesis Sponsor: National Institutes of Health (NIH) |
||
|
Title: TRACKING OF UPPER EXTREMITY ADAPTATION AND INJURY IN ADOLESCENT BASEBALL PLAYERS Sponsor: National Institutes of Health (NIH) |
||
|
Title: Training Program for the Next Generation of Oral Health Researchers
(NextGen). Sponsor: National Institutes of Health (NIH) |
||
|
Title: Training the Globally Ready Scholar Sponsor: University of Pennsylvania |
||
|
Title: Translational characterization of arachidonic acid metabolism in vascular inflammation and cardiovascular disease. Sponsor: American Heart Association - Mid Atlantic Affiliate |
||
|
Title: Translational Evaluation of Cytochrome P450 Eicosanoid Metabolism as a Therapeutic Target for Cardiovascular Disease Sponsor: American Heart Association |
||
|
Title: UNC BIRCWH Career Development Program Sponsor: National Institutes of Health (NIH) |
||
|
Title: Uncertainty in Adolescent and Young Adults with Congenital Heart Disease Sponsor: American Nurse's Foundation, Inc |
||
|
Title: Understanding Racial Variation in Endocrine Therapy Utilization & Adherence Sponsor: Susan G. Komen Breast Cancer Foundation |
||
|
Title: Understanding the Influence of Concussion Education on Knowledge, Attitudes, and Behaviors Concerning Concussion among Youth Athletes, Coaches, and Parents Sponsor: National Operating Comm. on Standards for Athletic Equipment |
||
|
Title: Understanding the mechanism of Ror2 towards anti-cancer drug development Sponsor: American Cancer Society |
||
|
Title: University of North Carolina AIDS Clinical Trials Unit (UNC ACTU) HPTN 069 & ACTG Sponsor: National Institutes of Health (NIH) |
||
|
Title: University of North Carolina AIDS Clinical Trials Unit (UNC ACTU) HPTN 069-Tissue Subset Study Sponsor: National Institutes of Health (NIH) |
||
|
Title: Use Of Local Ablation To Sites Of Progressive Disease To Restore Systemic Sensitivity To EGFR Tyrosine Kinase Inhibition In Patients With EGFR Mutation Progressing On 1st Line EGFR Tyrosine Kinase Inhibitors Sponsor: National Lung Cancer Partnership |
||
|
Title: Using new mouse models to dentify antioxident roles in diabetic nephropathy Sponsor: Georgia Health Sciences University |
||
|
Title: Using new mouse models to identify antioxidant roles in diabetic nephropathy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Using Tailored Videos to Improve Inhaler Technique for Children with Asthma Sponsor: National Institutes of Health (NIH) |
||
|
Title: Validation of mast-cell tryptase staining for diagnosis of eosinophilic esophagitis Sponsor: American Gastroenterological Association Foundation |
||
|
Title: VasoWave Ex Vivo Perfusion of Liver Tissue Sponsor: Smart Perfusion LLC |
||
|
Title: Vitamin D for Enhancing the Immune System in Cystic Fibrosis Sponsor: Emory University |
||
|
Title: VX09-809-102 A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of VX-809 Alone in Combination with VX-770 in subjects with Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation. Sponsor: Vertex Pharmaceuticals, Inc. |
||
|
Title: Weight Management in Hispanic Women and Prevention of Weight Gain in Children Sponsor: National Institutes of Health (NIH) |
||
|
Title: Whole Kinome Profiling and Remodeling in HER2+ Breast Cancer Sponsor: Susan G. Komen Breast Cancer Foundation |
||
|
Title: Whole-Exome Sequencing to Define the Genetic Basis of Unusual Forms of Primary Ciliary Dyskinesia and "Idiopathic Bronchiectasis" Sponsor: National Institutes of Health (NIH) |
||
|
Title: Wong Career Development: Early Childhood Social-Cognitive Interventions in Autism Sponsor: National Institute of Mental Health-NIH |
||
|
Title: WS1365413 Effect of growth hormone on early brain development in girls with NON-MONOSOMIC Turner Syndrome Sponsor: Pfizer, Inc. |
||
|
Title: WV21913 A Randomized, Open-label, Multicenter Study to Evaluate the Sustained Virologic Response of the HCV Protease Inhibitor Danoprevir Boosted with Low Dose Ritonavir (DNV/r) and Copegus, in Combination with the HCV Polymerase Inhibitor Prodrug RO5024048 and/or Pegasys in Chronic Hepatitis C Genotype 1 Patients Who Failed with a Previous Course of Peginterferon alfa plus Ribavirin Combination Therapy Sponsor: Genentech, Inc. |
||
|
Title: Y-55-52120-140 A phase III, multicentre, double-blind, prospective, randomised, placebo-controlled study assessing the efficacy and safety of DYSPORT used in the treatment of lower limb functional impairment in adult subjects with spastic hemiparesis due to stroke or traumatic brain injury Sponsor: Tercica, Inc. |
||
|
Title: Y-55-52120-142 A phase III, prospective, multicentre, open label, extension study, to assess the long term safety and efficacy of repeated treatment of DYSPORT intramuscular injection in the treatment of lower limb spasticity in adult subjects with spastic hemiparesis due to stroke or traumatic brain injury Sponsor: Tercica, Inc. |
||
|
Title: YTW-52120-145 A Phase III, multicentre, double-blind, prospective, randomized, placebo-controlled study, assessing the efficacy and safety of Dysport intramuscular injections used for the treatment of upper-limb spasticity in adult subjects with spastic hemiparesis due to stroke or traumatic brain injury Sponsor: Tercica, Inc. |
||
| ||
|
Title: 09-OA-003 A Phase I, Double Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphongenetic Protein (38A BMP-7) in subjects with Osteoarthritis of the Knee Sponsor: INC Research, Inc. |
||
|
Title: 0924401 Evaluation of the Clinical Performance of Determine HIV-1/2 Ag/Ab Combo Sponsor: Alere Scarborough, Inc. |
||
|
Title: 09PAN01 A Phase 1b Study of Erlotinib in Combination with Gemcitabine and nab-Paclitaxel in Patients with Previously Untreated Advanced Pancreatic Cancer Sponsor: Aptium Oncology |
||
|
Title: 1001 A Phase III, Multinational, Randomized, Double-Blind, Placebo-Controlled, parallel-Group Study to investigate the Clinical Efficacy and Safety of DiaPep277 in Newly Diagnosed Type 1 Diabetes Subjects Sponsor: i3 Research |
||
|
Title: 102-21/WA17531 An open label study of the efficacy and safety of re-treatments with rituximab (MabThera/Rituxan) in patients with active rheumatoid arthritis who have had an inadequate Response To Anti-Tnfa Therapies Sponsor: Biogen, Inc. |
||
|
Title: 156-08-271 Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Sponsor: Covance, Inc. |
||
|
Title: 2009120 A Multicenter, Multidose, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy of a Probiotic (Bifidobacterium infantis 35624) in Subjects with a History of Abdominal Pain/Discomfort and Bloating Sponsor: Procter and Gamble Company |
||
|
Title: 20801 Phase 1/2, Prospective, Dose-Escalation/Finding Study to Evaluate Pharmacokinetics and Immediate Tolerability of Recombinant Activated FVII (rFVIIa BI) in Patients with Hemophilia A or B and Inhibitors Sponsor: Baxter Healthcare Corporation |
||
|
Title: 28431754-DIA-3004 A Randomized, Double Blind, Placebo-Controlled, 3-Arm, Parallel-Group, 26-Week, Multicenter Study With a 26-Week Extension, to Evaluate the Efficacy, Safety and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus Who have Moderate Renal Impairment Sponsor: Johnson and Johnson |
||
|
Title: 28431754-DIA-3008 A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of JNJ 28431754 on Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Mellitus (the CANVAS Trial) Sponsor: Johnson and Johnson |
||
|
Title: 3M Study -5-011091 A Multi-centered, Prospective, Randomized, Double-blinded, Comparison of an Investigational Non-adherent Dressing to 3M Tegaderm Matrix Dressing with PHI Technology in the Management of Non-healing Diabetic Foot Ulcers Sponsor: 3M PHARMACEUTICALS |
||
|
Title: 998HB102 An OL, Multicenter Evaluation of the Safety, Pharmacokinetics, & Efficacy of Recombinant, Long Acting Coagulation Factor IX Fc Fusion (rFIXFc) in the Prevention & Treatment of Bleeding in Previously Treated Subjects with Severe Hemophilia B Sponsor: Biogen, Inc. |
||
|
Title: A collaborative model to improve BP control and minimize racial disparities CCC Sponsor: University of Iowa |
||
|
Title: A Composite Score of Whole-body Radiographic OA Sponsor: American College of Rheumatology Res and Education Fdn |
||
|
Title: A Longitudinal MRI Study of Brain Development in Fragile X Syndrome Sponsor: National Institute of Child Health and Human Development (NICHD) |
||
|
Title: A Mindfulness-based Intervention to Reduce Diabetes Risk in Prediabetic African-Americans Sponsor: National Center for Complementary and Alternative Medicine |
||
|
Title: A novel mechanism of coagulation in sickle cell disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: A Phase I/II Investigation of the Effect of Vorinostat (VOR) in HIV Infection Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: A Randomized Feasibility Trial of a Polypill for Primary Prevention of Cardiovascular Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: A social-ecological approach to address breastfeeding disparities through community based participatory research Sponsor: National Institutes of Health (NIH) |
||
|
Title: A2AR Allosteric Modulators as a Novel Treatment of Alzheimer's Disease Sponsor: Alzheimer's Association |
||
|
Title: Activation of Coagulation in Sickle Cell Trait Sponsor: National Institutes of Health (NIH) |
||
|
Title: Adapting Project SAFE/Reducing STD/HIV Risk in Women Prisoners Sponsor: Centers for Disease Control and Prevention (CDC) |
||
|
Title: Adenosine and its receptors as therapeutic targets for chronic rhinosinusitis Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: AGS-NTS-012 A Study of HIV-Infected Subjects Initiating ART for the First Time for the Purpose of Obtaining Pre-Therapy HIV RNA to Qualify Subjects for the Subsequent HIV RNA-Electroporated Dendritic Cell Immunization Study Sponsor: Argos Therapeutics, Inc. |
||
|
Title: AIDS Clinical Trial Group Network (ACTG) A5254 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: AIDS Clinical Trials Group Network (ACTG) A5267 Sponsor: Social and Scientific Systems, Inc |
||
|
Title: Ammerman Faith-Based Sponsor: National Institutes of Health (NIH) |
||
|
Title: Anesthesiology Pain Management Fellowship Sponsor: Boston Scientific Foundation |
||
|
Title: Assessment and Support of Achieving Prevention (ASAP) Phase II Sponsor: Kate B. Reynolds Charitable Trust |
||
|
Title: Automatic Atlas-based Muscle MRI Segmentation in Duchenne Muscular Dystrophy Sponsor: Muscular Dystrophy Association |
||
|
Title: B171023_3001 A Prospective, Multicenter, Open-label, Phase 3b Study of Human Plasma-Derived Factor XIII Concentrate in Subjects with Congenital Factor XIII Deficiency Sponsor: CSL Behring Foundation |
||
|
Title: BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Barrett's Esophagus Translational Research Network (BETRNet) Sponsor: Case Western Reserve |
||
|
Title: BI71023_3002 A Prospective, Multicenter, Open Enrollment Study of Human Plasma-Derived Factor XIII Concentrate in Subjects with Congenital Factor XIII Deficiency Sponsor: CSL Behring GmbH |
||
|
Title: Biocompatible Biodegradable Multifunctional Targeted Nanoparticles Delivering Gemcitabine Triphosphate and 111Indium as a Novel Theranostic Agent Sponsor: Qualiber, Inc. |
||
|
Title: BR1-130 Characterization of Focal Liver Lesions with SonoVue-Enhanced Ultrasound Imaging: A Phase III, Intrapatient Comparative Study versus Unenhanced Ultrasound Imaging Using Histology or Combined Imaging/Clinical Data as Truth Standard Sponsor: Bracco Diagnostics, Inc. |
||
|
Title: Breaking chemoresistance in CLL by targeting a novel stromal cell gene Sponsor: Leukemia and Lymphoma Society of America |
||
|
Title: BUCF30001 A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Budesonide Foam (2mg/25ml BID for 2 Weeks, Followed By 2mg/25ml QD for 4 Weeks) Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis Sponsor: Salix Pharmaceuticals, Inc. |
||
|
Title: BUCF3001 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Budesonide Foam (2mg/25ml BID for 2 weeks, followed by 2mg/25ml QD for 4 weeks) Versus Placebo in Subjects with Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis. Sponsor: Salix Pharmaceuticals, Inc. |
||
|
Title: Building Local Food Systems in Rural North Carolina: Warren County Region Demonstration Project Sponsor: Golden LEAF Foundation, Inc. |
||
|
Title: C014001 An Open-label, Dose Escalation Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors Sponsor: Millennium Pharmaceuticals, Inc. |
||
|
Title: C33457/2047 A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of CEP-33457 in Patients With Systemic Lupus Erythematosus Sponsor: Cephalon, Inc. |
||
|
Title: Cancer and Leukemia Group B Foundation Funding Sponsor: Cancer and Leukemia Group B-University of Chicago |
||
|
Title: CAREER: Optical coherence microrheology in 3D tissues and tissue models Sponsor: National Science Foundation - Research (NSF) |
||
|
Title: Carolina Data Warehouse for Health: Link to NC Community Care Networks
Proposal to The Duke Endowment from The UNC School of Medicine Sponsor: The Duke Endowment |
||
|
Title: Cellular Determinants of Fibrin Structure and Stability Sponsor: National Institutes of Health (NIH) |
||
|
Title: Center for Genomics and Society ELSI conference Sponsor: National Institutes of Health (NIH) |
||
|
Title: Center for HIV/AIDS Vaccine Immunology (CHAVI)-CHAVI 001 Sponsor: Duke University |
||
|
Title: Central Pain Dysregulation in Patients with Irritable Bowel Syndrome (IBS) Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: CFAR Network of Integrated Clinical Systems Sponsor: University of Alabama at Birmingham |
||
|
Title: Characterization of Normal Brain Development Using Parallel MRI Sponsor: National Institutes of Health (NIH) |
||
|
Title: Chavala Hope for Vision grant Sponsor: Hope for Vision |
||
|
Title: Chemical Agent Identifying Device Sponsor: Identizyme Defense Technologies, Inc. |
||
|
Title: Clinical Research Training in Oral Diseases for Future-Cost Extension Sponsor: National Institutes of Health (NIH) |
||
|
Title: Clinical testing for peanut allergens Sponsor: North Carolina Agriculture and Technology State - NC AT |
||
|
Title: CNTO328MCD2001 A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of CNTO 328 (Anti-IL-6 Monoclonal Antibody) Plus Best Supportive Care Compared With Best Supportive Care in Subjects With Multicentric Castlemans Disease Sponsor: Centocor, Inc. |
||
|
Title: CNTO328MMY2001 A Randomized, Open-label, Phase 2 Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma Sponsor: Centocor, Inc. |
||
|
Title: COAGULATION ACTIVATION IN SICKLE CELL DISEASE- ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Collaborative Research: Magneto-Optical Plasmonic Nanoprobes for Molecular
Optical Coherence Imaging Sponsor: National Science Foundation - Research (NSF) |
||
|
Title: Communication About Glaucoma and Patient Outcomes Sponsor: National Eye Institute |
||
|
Title: Communities Putting Prevention to Work: Development of a Resource Center for Community Action Sponsor: Macro International |
||
|
Title: Community-level Deprivation and Access to Health Care in the Rural South Sponsor: National Institutes of Health (NIH) |
||
|
Title: Comparative Safety of antiretrovirals among HIV-infected patients: minimizing coronary heart disease outcomes Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Computer Modeling of Sinus Surgery Effects on Topical Drug Delivery in the Nose Sponsor: National Institutes of Health (NIH) |
||
|
Title: Connect to Fitness-CP: Feasibility and Effect of a virtually supported, community-based fitness and wellness program on activity level, participation and functional outcomes in adults with cerebral palsy Sponsor: American Academy for Cerebral Palsy and Developmental Medicine |
||
|
Title: Connecting Primary Care Practices with Hard-to-Reach Adolescent Populations Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Contrasting the Brain Effects of Risperdal and Invega with fMRI and PET Scanning Sponsor: University of California at Irvine |
||
|
Title: CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) Sponsor: University of Toledo - Toledo, Ohio |
||
|
Title: Creation and demonstration of a collaborative, multi-site, palliative care research network to reinvigorate biomedical research in Palliative Medicine Sponsor: Duke University Medical Center |
||
|
Title: Cross-species Investigation of the Impact of Obesity on Ovarian Cancer Sponsor: Marsha Rivkin Center for Ovarian Cancer Research |
||
|
Title: Cross-species Investigation of the Impact of Obesity on Ovarian Cancer Pathogenesis Sponsor: Ovarian Cancer Reseach Fund, Inc. |
||
|
Title: Cross-species Investigation of the Impact of Obesity on Ovarian Cancer Pathogenesis Sponsor: Gynecologic Cancer Foundation |
||
|
Title: CTRC-1419 A Study of Long-Term Human Recombinant Insulin-Like Growth Factor-I (rhIGF-I) Treatment in Children with Short Stature Due to Growth Hormone Insensitivity Syndrome (GHIS) Sponsor: Tercica, Inc. |
||
|
Title: Decision Support Lab - Breast Cancer Project Sponsor: Foundation for Informed Medical Decision Making |
||
|
Title: Decreasing Health-Related Stigma in Adults with Sickle Cell Disease Sponsor: National Institute of Nursing Research |
||
|
Title: Determination of the mechanisms by which IGFBP-2 stimulates bone remodeling Sponsor: Maine Medical Center |
||
|
Title: Determining the Phenotype: Genotype Correlation in Human Tooth Agenesis Sponsor: National Institutes of Health (NIH) |
||
|
Title: Developing a National Infrastructure for Clinical Translational Research Sponsor: AAFP National Research Network |
||
|
Title: Development of National Informatics Infrastructure for Pediatric CE Research Sponsor: Children's Hospital Medical Center of Cincinnati |
||
|
Title: Development of Nanoparticle Gemcitabine Monophosphate (NanoGemp) as a Novel Anticancer Drug Sponsor: Qualiber, Inc. |
||
|
Title: Dimensionality: Ethnicity-based, Lifecourse, Intergenerational Theory of Equity (ELITE) Sponsor: National Institutes of Health (NIH) |
||
|
Title: DNA damage response analysis for Eisai PARP inhibitors Sponsor: Eisai Medical Research Inc |
||
|
Title: Does Centering Pregnancy Reduce Stress among African American women? Sponsor: Aetna Foundation |
||
|
Title: Down-regulation of oxidant-induced airway inflammation though modulation of Nrf2 Sponsor: National Institute of Environmental Health Sciences |
||
|
Title: DPSI-IDP-108-P3-02 A Phase 3, Multicenter, Randomized, Double-Blind Study Evaluating the Safety and Efficacy of IDP-108 Topical Solution versus Vehicle in Subjects with Mild to Moderate Onychomycosis of the Toenails Sponsor: Dow Pharmaceutical Sciences, Inc. |
||
|
Title: DRC-0651 Studies of Clinical and Biofilm Responses in Human Gingivitis and Periodontitis: Effects of Sonicare-Flexcare Sponsor: Philips Oral Healthcare, Inc. |
||
|
Title: DRC-0651 Studies of Salivary Inflammatory Biomarkers During Biofilm Overgrowth: Confirmation of Predictors and Comparative Effects of Sonicare/elite-flexcare in Various Stages of Periodontal Disease Sponsor: Philips Oral Healthcare, Inc. |
||
|
Title: Drug-Induced Liver Injury Network (DILIN) Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: Early MRSA therapy in CF - Culture based vs. observant therapy (treat or observe) Sponsor: Cystic Fibrosis Foundation Therapeutics, Inc. |
||
|
Title: Early Sepsis Diagnostic via Nitric Oxide Sensor Sponsor: Clinical Sensors, Inc |
||
|
Title: Effect of a Comprehensive Child Sexual Abuse Invstigative Model on Child Disclosure and Criminal Justice Outcomes Sponsor: National Institute of Justice |
||
|
Title: Efficacy of NF-kB as a target for Therapy in Parkinson's Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Eighth International Symposium on Tooth Enamel: Development, Properties and Pathology Sponsor: National Institutes of Health (NIH) |
||
|
Title: Elusive Deformable Tissue Engineered Cartilage: Focus on Elastin Sponsor: Plastic Surgery Education Foundation |
||
|
Title: Enhanced Formalin Fixation to Improve Tests on Solid Tissues Sponsor: National Institutes of Health (NIH) |
||
|
Title: Enhanced Registries for Quality Improvement and Comparative Effectiveness Research (R01) Sponsor: Children's Hospital Medical Center of Cincinnati |
||
|
Title: Enhancing Pediatric Patient Involvement in Care (EPPIC) Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: Epic Observational Sponsor: Seattle Children's Research Institute |
||
|
Title: Epidemiology study focused on the association between respiratory events and oral status comparing edentulous versus dentate populations Sponsor: GlaxoSmithKline, Inc |
||
|
Title: Establishing continuity of care for smoking cessation from inpatient to outpatient settings Sponsor: Pfizer Health Foundation |
||
|
Title: Expansion, testing and dissemination of a GIS-based direct market locator tool (Geolocator) to maximize farmer revenue and increase healthy food access via EBT. Sponsor: US Department of Agriculture |
||
|
Title: Exploring salivary biomarkers for Diabetes Sponsor: National Institutes of Health (NIH) |
||
|
Title: Exploring salivary surrogate biomarkers for serum A1C Sponsor: American Diabetes Association |
||
|
Title: Faith-Based Cardiovascular Disease Prevention Study Sponsor: National Center on Minority Health and Health Disparities (NCMHD) |
||
|
Title: Feasibility and Pilot Study of Chromium Picolinate for Binge Eating Sponsor: National Institutes of Health (NIH) |
||
|
Title: Flexible Cartilage in Microtia Repair: Umbilical Cord Stem Cells On Nano-Implants Sponsor: American Academy of Otolaryngology-Head and Neck Fdn., Inc |
||
|
Title: FMR1 CGG Repeats In Premature Ovarian Insufficiency Women vs. 3 Comparison Groups Sponsor: University of Virginia |
||
|
Title: FMR1 CGG Repeats In Primary Ovarian Insufficiency Women vs. 2 Comparison Groups Sponsor: University of Virginia |
||
|
Title: FSGS Clinical Trial Longitudinal Study Sponsor: University of Michigan |
||
|
Title: FSH as a Biomarker of Bone Strength in Younger Postmenopausal Women Sponsor: National Institutes of Health (NIH) |
||
|
Title: Function and regulation of OATP1B1 and OATP1B3 Sponsor: National Institutes of Health (NIH) |
||
|
Title: Functionalized Amino Acid Amides: New Neurological Agents with Diverse Activities Sponsor: National Institutes of Health (NIH) |
||
|
Title: G protein-coupled receptor kinase 3 regulation of leukocyte function in inflammatory arthritis Sponsor: National Institutes of Health (NIH) |
||
|
Title: Gene Modifiers in CF Lung Disease Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: Genetic Disorders of Mucociliary Clearance Sponsor: National Institutes of Health (NIH) |
||
|
Title: Genetic Modifiers of CF Liver Disease Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: GENOME-WIDE ASSOCIATION STUDY OF PERIODONTAL DISEASE Sponsor: National Institutes of Health (NIH) |
||
|
Title: Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia Sponsor: National Institutes of Health (NIH) |
||
|
Title: GS-US-205-0127 Phase 3b Randomized, Double-Blind, Placebo-Controlled Two-Part Trial to Assess the Safety and Efficacy of Continuous Aztreonam for Inhalation Solution (AZLI) in Subjects with Cystic Fibrosis (CF) and Chronic Burkholderia Species InfectionGilea Sponsor: Gilead Sciences, Inc. |
||
|
Title: Guide to Healing: Enhancing Access for HIV+ Women in the Rural South Sponsor: Health Resources and Services Administration |
||
|
Title: Guiding Mothers to Co-Regulate Oral Feedings With Very Preterm Infants Sponsor: National Institute of Nursing Research |
||
|
Title: Gut microbiota establishment in infants and predisposition to food allergy Sponsor: University of Nebraska |
||
|
Title: H9X-MC-GBDA A randomized placebo-controlled comparison of the effects of two doses of LY2189265 or Exenatide on glycemic controll in patients with type 2 diabetes on stable doses of metformin and pioglitazone AWARD-1 Sponsor: Eli Lilly and Co. |
||
|
Title: HGT-HIT-046: An Open-Label Extension of Study HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Intrathecal Idursulfase-IT, Administered in Conjunction with Intravenous Elaprase, in Pediatric Patients with Hunter Syndrome and Early Cognitive Impairment Sponsor: Shire Human Genetic Therapies, Inc. |
||
|
Title: HPA Stress Reactivity & Genetic Influences in Postpartum Depression Sponsor: National Institutes of Health (NIH) |
||
|
Title: HPTN 066 Sponsor: Family Health International |
||
|
Title: Human Requirements for the Nutrient Choline Progress Report Sponsor: National Institutes of Health (NIH) |
||
|
Title: IDE G050233 Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial(CABANA) Sponsor: Duke Clinical Research Institute |
||
|
Title: Identification of Neurobiologically-Defined Subgroups in Autism with Significance for Intervention
Efficacy: Neurophysiological Markers of a Parent-Mediated Intervention for One-Year-Olds at-Risk for
Autism Sponsor: Congressionally Directed Medical Research Programs (CDMRP) |
||
|
Title: Identification of small molecule HO-1 inducers as therapeutics for IBD Sponsor: National Institute of Neurologic Disorders and Stroke |
||
|
Title: Identification of Small Molecules for Treating Autism Spectrum Disorders Sponsor: Simons Foundation |
||
|
Title: Identifying Metabolic Alterations in Pancreas Cancer Sponsor: National Institutes of Health (NIH) |
||
|
Title: IFN4575g A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rontalizumab (rhuMAb IFNalpha) In Patients With Moderately To Severely Active Systemic Lupus Erythematosus Sponsor: Genentech, Inc. |
||
|
Title: Immediate ART in Acute HIV: Attacking the Pathogenesis of Persistent Infection Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Immune Mechanisms of Exacerbated Pathogenesis in HIV-Malaria Co-Infection Sponsor: National Institutes of Health (NIH) |
||
|
Title: Immunobiology of Acute Environmental Asthma Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Impact of Biological Variation in A1c on Mortality, Cardiovascular Events, and Hypoglycemia in the ACCORD Study Sponsor: Children's Hospital of New Orleans |
||
|
Title: Implementation of a vaginal/rectal HIV Transmission Model to Evaluate Microbicides Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Implementing Practice Coaching and the Chronic Care Model in Practices Serving Vulnerable Populations Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Implementing Trauma-Informed Services in Community Practice Sponsor: Substance Abuse and Mental Health Services Admininstration |
||
|
Title: Improving Outcomes for Women with GDM and their Infants Sponsor: National Institutes of Health (NIH) |
||
|
Title: Improving Patient Safety in a Pediatric Service Line Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: In Vitro Model to Study Periosteal-Keratinocyte Interaction for Acellular Bone Coverage Sponsor: American College of Surgeons |
||
|
Title: In-Cell NMR of Disease-Related Proteins Sponsor: National Institutes of Health (NIH) |
||
|
Title: Influence of Vitamin D on SLE Nephritis Activity, Drug Metabolism, and Transport Sponsor: National Institutes of Health (NIH) |
||
|
Title: ING111762 A Phase III Randomized, Double-Blind Study of the Safety and Efficacy of GSK 1349572 50 mg Once Daily Versus Raltegravir 400 mg Twice Daily, Both Administered with an Investigator-Selected Background Regimen over 48 weeks in HIV-1 Infected, Integrase Inhibitor-Naive, Antiretroviral Therapy-Experienced Adults Sponsor: GlaxoSmithKline, Inc |
||
|
Title: Innovative Therapies to eliminate persistent HIV infection Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Integrating Primary Care Practices and Community-based Programs to Manage Obesity Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Integrating Public Health, Policy, and Planning to Reduce Health Disparities Sponsor: National Institutes of Health (NIH) |
||
|
Title: Investigating gene x environment interaction using human exposures to O3 & LPS - ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: ITN034AI A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs. Cyclophosphamide Alone in the Treatment of Lupus Nephritis Sponsor: University of California at San Francisco |
||
|
Title: Kelloggs Community Health Scholars Sponsor: Center for Advancement of Health |
||
|
Title: Lactation Effects on Postnatal Endothelial Function and Vascular Inflammation Sponsor: National Institutes of Health (NIH) |
||
|
Title: LCCC 0909 A Pharmacokinetic Study Of Oral And Intravenous Clofarabine In Patients With High Grade Myelodysplasia And Acute Leukemias-Determination Of Oral Bioavailability And The Effect Of Cimetidine On Clofarabine Clearance Sponsor: Genzyme Corporation |
||
|
Title: Lubiprostone Effects on Visceral Pain Sensitivity Sponsor: Takeda Pharmaceuticals North America, Inc. |
||
|
Title: Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention Sponsor: American Cancer Society |
||
|
Title: Martin Delaney Collaboratory to Eradicate HIV-1 Infection Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mechanism of Phenotype/Genotype Relationships in Dentinogenesis Imperfecta Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mechanisms of Venous Thromboembolism in Cancer Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mechanisms Underlying Drug-Diet Interactions Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mentoring in community influences on CVD risk Sponsor: National Heart Lung and Blood Institute |
||
|
Title: Mindfulness: a novel approach for the management of diabetes-related distress Sponsor: National Institutes of Health (NIH) |
||
|
Title: Molecular Epidemiology of HIV-infected Latinos in North Carolina Sponsor: National Institutes of Health (NIH) |
||
|
Title: Molecular Mechanisms of CFTR Function Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: Molecular Stratification of Renal Cell Carcinoma to Predict Response to Treatment Sponsor: Cancer and Leukemia Group B-University of Chicago |
||
|
Title: MOTOR - Maternal Oral Therapy to Reduce Obstetric Risk Sponsor: National Institutes of Health (NIH) |
||
|
Title: MUC-1 related cancer immunity: determinants and predictive significance Sponsor: Brigham and Women's Hospital |
||
|
Title: Mucus Adhesion to Epithelial Cells and its Mobilization in COPD and CF Sponsor: National Heart Lung and Blood Institute |
||
|
Title: Myeloid Derived Suppressor Cells in Type 1 Diabetes Mellitus Sponsor: The Doris Duke Foundation |
||
|
Title: NC25113A A randomized double blind placebo controlled clinicla trial to assess the effects of taspoglutide on cardiovascular outcomes in subjects with inadequately controlled type 2 diabetes and established cardiovascular disease Sponsor: Hoffman-LaRoche Inc. |
||
|
Title: Neuroprotective Peptides for the Treatment of Traumatic Brain Injury Sponsor: National Institutes of Health (NIH) |
||
|
Title: Neutron-Activatable Nanoparticles for Targeted Radionuclide Therapy of Tumors Sponsor: National Institutes of Health (NIH) |
||
|
Title: NICHD Neonatal Research Network--Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study: ELGAN BP Trial Sponsor: Duke University |
||
|
Title: NICHD Neonatal Research Network--Early Onset Sepsis Sponsor: Duke University |
||
|
Title: NICHD Neonatal Research Network--ELGAN BP Pilot Study - Prospective Time Limited Data Collection Sponsor: Duke University |
||
|
Title: NICHD Neonatal Research Network--Multidose Pharmacokinetics and dose ranging of inositol in premature infants Sponsor: Duke University |
||
|
Title: NICHD Neonatal Research Network--Necrotizing Enterocolitis Surgery Trial (NEST) Sponsor: Duke University |
||
|
Title: NICHD Neonatal Research Network--Single Dose Vitamin E for Prevention of Mortality and Morbidity in Extremely Preterm Infants: Pilot Study Sponsor: Duke University |
||
|
Title: NN1250-3644 An extension trial to trial NN1250-3583 comparing safety and efficacy of NN1250 with insulin glargine, both with insulin aspart as meal time insulin, in type 1 diabetes Sponsor: Novo Nordisk Pharmaceuticals, Inc. |
||
|
Title: NN1250-3672 A trial comparing efficacy and safety of NN1250 and insulin glargine in subjects with type 2 diabetes BEGIN: LOW VOLUME Sponsor: Novo Nordisk Pharmaceuticals, Inc. |
||
|
Title: NN1250-3770 A 26-week, randomized, controlled, open-label, Multi-centre, Multi-national, Three-arm, Parallel, Treat-to-Target Trial Comparing Efficacy and Safety of Two Different Dosing Regiments of SIBA and one Dosing Regiment of Insulin Glargine, both in Combination with Meal-time Insulin-Aspart in Subjects with Type I Diabetes Mellitus Sponsor: Novo Nordisk Pharmaceuticals, Inc. |
||
|
Title: NN1250-3770 A 26-week, randomized, controlled, open-label, Multi-centre, Multi-national, Three-arm, Parallel, Treat-to-Target Trial Comparing Efficacy and Safety of Two Different Dosing Regiments of SIBA and one Dosing Regiment of Insulin Glargine, both in Combination with Meal-time Insulin-Aspart in Subjects with Type I Diabetes Mellitus Sponsor: Novo Nordisk Pharmaceuticals, Inc. |
||
|
Title: Novel A2AR Allosteric Modulators as a Treatment of Alzheimer's Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Novel Therapies for Muco-Obstructive Lung Diseases Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: Obesity, Metformin and Endometrial Cancer Sponsor: The Doris Duke Foundation |
||
|
Title: Optical Coherence Imaging of the Breast Mechanical Microenvironment in 3D Using Magneto-Optical Nanoparticles Sponsor: Congressionally Directed Medical Research Programs (CDMRP) |
||
|
Title: Optimizing Antiretroviral Use in Aging: Pharmacokinetics, Response, and Toxicity Sponsor: National Institutes of Health (NIH) |
||
|
Title: Oxytocin treatment of social cognition and function deficits in schizophrenia Sponsor: The Stanley Medical Research Institute |
||
|
Title: Oxytocin Treatment of Social Cognition and Functional Deficits in Schizophrenia Sponsor: National Alliance Res on Schizophrenia and Depression (NARSAD) |
||
|
Title: Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia Sponsor: National Institutes of Health (NIH) |
||
|
Title: p3k112826 A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK2126458 in Subjects with Solid Tumors or Lymphoma Sponsor: Glaxo SmithKline Foundation |
||
|
Title: P7977-0422 A Multi-center, Placebo-Controlled, Dose Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics following Oral Administration of PSI-7977 in Combination with Pegylated Interferon and Ribavirin in Treatment-Nave Patients with Chronic HCV Infection Genotype 1, and an Open Label Assessment of PSI-7977 in Patients with HCV Genotypes 2 or 3 Sponsor: Pharmasset, Inc |
||
|
Title: Partnership to Promote CVD Prevention and Meaningful EHR Use in Primary Care Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Pathogenesis of PCD Lung Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Patient Decision Making about Breast Reconstruction after Mastectomy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Patient Decision Making about Breast Reconstruction after Mastectomy. Sponsor: National Institutes of Health (NIH) |
||
|
Title: Pediatric Inflammatory Bowel Disease Registry Sponsor: Connecticut Children's Medical Center |
||
|
Title: People's Garden School Pilot Program Sponsor: US Department of Agriculture |
||
|
Title: Perinatal Nicotine and Auditory Evoked Potentials in Early Infancy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Persistent COMT-dependent Pain: Role of -adrenergic Pathways Sponsor: National Institutes of Health (NIH) |
||
|
Title: Persistent COMT-dependent Pain: Role of beta-adrenergic Receptors Sponsor: National Institutes of Health (NIH) |
||
|
Title: Phase II study of valacyclovir and cyclophosphamide for endemic Burkitt lymphoma Sponsor: National Institutes of Health (NIH) |
||
|
Title: Phenotypic and Genotypic Predictors of Pain and PTSD Outcomes After SANE Care Sponsor: National Institute of Nursing Research |
||
|
Title: Physical Contributors to Throwing Injuries: A Prospective Study Sponsor: National Institutes of Health (NIH) |
||
|
Title: Population-based Assessment of Breast MRI Utilization in Patients with Newly Diagnosed Breast Cancer. Sponsor: American College of Surgeons |
||
|
Title: Predictive Modeling for Treatment of Upper Airway Obstruction in Young Children Sponsor: National Institutes of Health (NIH) |
||
|
Title: Preliminary Efectiveness Analysis of Universal Rotavirus Immunization, Nicaragua Sponsor: Fogarty International Center |
||
|
Title: Prenatal arsenic exposure and newborn health effects Sponsor: National Institutes of Health (NIH) |
||
|
Title: Prevention Center for Healthy Weight Sponsor: Health Resources and Services Administration |
||
|
Title: Progesterone Action in the Endometrium of Women with Endometriosis Sponsor: National Institutes of Health (NIH) |
||
|
Title: Psychophysiology of Irritable Bowel Syndrome Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: PTC124-GD-009-CF A Phase 3 Efficacy and Safety Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis Sponsor: PTC Therapeutics, Inc. |
||
|
Title: PTI-LC-2010-02 Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures Sponsor: Pathfinder Therapeutics, Inc. |
||
|
Title: Pulmonary, Critical Care, and Molecular Training Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: Quantitative Proteomic Analysis of Cilia and Functional Studies of Novel Proteins Sponsor: National Institutes of Health (NIH) |
||
|
Title: R01: Admin Supplement - Evaluation of cytochrome P450-mediated eicosanoid metabolism as a therapeutic target in patients with established coronary artery disease Sponsor: NIH Clinical Center |
||
|
Title: Radiation-Induced Osteoporosis in Women with Cancer: Mechanisms and Prevention Sponsor: National Institutes of Health (NIH) |
||
|
Title: Randomized Trial of University-AAA-State Partnership to Link Primary Care Physicians and Aging Service Providers in the Support of Persons with Alzheimer's Disease and Related Disorders (ADRD) Sponsor: United States Administration on Aging |
||
|
Title: RCT of an augmented test, treat, link & retain model for NC and Texas prisoners Sponsor: National Institutes of Health (NIH) |
||
|
Title: Refining Diagnostic Criteria of a Pain Disorder: Vulvar Vestibulitis Syndrome Sponsor: National Institute of Child Health and Human Development (NICHD) |
||
|
Title: REGIONAL BRAIN MANGANESE ACCUMULATION AND FUNCTIONAL CONSEQUENCES IN WELDERS Sponsor: Pennsylvania State University |
||
|
Title: Regulated Hpothermia to Treat Hypoxic-Ischemic Brain Injury Sponsor: National Institutes of Health (NIH) |
||
|
Title: Regulation of adult ciliary body progenitor cells for cell replacement therapy Sponsor: National Institutes of Health (NIH) |
||
|
Title: Regulation of Leukemia Inhibitory Factor (LIF) for early embryo implantation Sponsor: National Institutes of Health (NIH) |
||
|
Title: Research Resident/Fellow Grant Sponsor: RSNA Research and Educational Foundation |
||
|
Title: Risk Factors and Biomarkers for Diagnosis & Treatment of Eosinophilic Esophagitis Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: Risk Factors and Biomarkers for Diagnosis and Treatment of Eosinophilic Esophagitis Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: RLX.CHF.003 A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure (RELAX) Sponsor: Corthera, Inc. |
||
|
Title: Role of Programmed Cell Death10 (PDCD10) in p38 MAP kinase activation and PDK1 signaling Sponsor: National Institutes of Health (NIH) |
||
|
Title: Salivary proteomic analysis for edentulous patients with and without type 2 diabetes Sponsor: American College of Prosthodontists |
||
|
Title: SCCOR in Host Factors in Chronic Lung Disease Sponsor: National Heart Lung and Blood Institute (NHLBI) |
||
|
Title: Scroll Wave Anchoring as a Cardiac Death Mechanism Sponsor: State University of New York (SUNY) |
||
|
Title: SEARCH for Diabetes in Youth, Phase 3: Registry Study - Carolina Center Sponsor: Centers for Disease Control and Prevention (CDC) |
||
|
Title: Serum biomarkers for age-related macular degeneration Sponsor: International Retinal Research Foundation |
||
|
Title: Setting a research agenda for improving birth outcomes - communities partnering for change Sponsor: National Institutes of Health (NIH) |
||
|
Title: SGN113399 A Phase 2b study to select a once daily oral dose of GSK2248761 in HIV-1 infected antiretroviral therapy experienced adults with non-nucleoside reverse transcriptase inhibitor (NNRT1) resistance. Sponsor: GlaxoSmithKline, Inc |
||
|
Title: SPIO-loaded RL Platelets for Novel Magnetomotive Ultrasound Imaging of Thrombosis Sponsor: National Institutes of Health (NIH) |
||
|
Title: Stress Effects on Executive Function in Individuals with Schizophrenia and Familial High Risk Sponsor: National Alliance Res on Schizophrenia and Depression (NARSAD) |
||
|
Title: Stroke Telemedicine Access Recovery (STAR) Project Sponsor: The Duke Endowment |
||
|
Title: Study of Secondary Conditions and Effects of Aquatic Intervention on Adult CP Sponsor: National Institutes of Health (NIH) |
||
|
Title: Sunbcontract with NORC of the University of Chicago DHHS De-Identified Data Sponsor: NORC at the University of Chicago |
||
|
Title: Surgical Delivery of Neo-Kidney Augment (NKA) Cellular Prototype to Treat Chronic Renal Failure - Phase I Sponsor: Tengion |
||
|
Title: Synereca Sponsored Research Agreement Sponsor: Synereca Pharmaccuticals, Inc |
||
|
Title: TDM4373g A Phase Ib/II, Open-Label Study Of The Safety, Tolerability, And Efficacy Of Trastuzumab-MCC-DM1 In Combination With Pertuzumab Administered Intravenously To Patients With Her2-Positive Locally Advanced Or Metastatic Breast Cancer Who Have Progressed While Receiving Prior Therapy Sponsor: Genentech, Inc. |
||
|
Title: The Effect of Pregnancy on the Pharmacokinetics of Isentress: A Longitudinal Investigation in the Second and Third Trimesters Sponsor: Merck Research Laboratories |
||
|
Title: The Effect of Probiotics on Luminal and Mucosal Microbiota in Humans Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Family Stories Program: An Early Childhood Drug Use Prevention Study Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Kellogg Health Scholars: Developing Leaders to Address Health Disparities Sponsor: Center for Advancement of Health |
||
|
Title: The Kellogg Health Scholars: Community Health Scholars Program Sponsor: University of Michigan |
||
|
Title: The National Children's Study: The North Carolina Study Center in Duplin County Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Quick CHEF (Cost-efficient, Healthy Easy Food) Program Sponsor: North Carolina Division of Social Services |
||
|
Title: The Role of Central Tolerance in Autoimmune Endocrinopathies Sponsor: Lawson Wilkins Pediatric Endocrine Society |
||
|
Title: The University of North Carolina Center for AIDS Research Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Vest Prevention of Early Sudden Death Trial (VEST) and PREDictions of ICD Therapies Study (PREDICTS) Sponsor: University of California at San Francisco |
||
|
Title: Tissue-Protective Cytokines for the Acute and Delayed Treatment of Spinal Cord Injury Sponsor: National Institutes of Health (NIH) |
||
|
Title: TMC114HIV4057 GRACE Participant Survey Sponsor: Tibotec Pharmaceuticals Ltd |
||
|
Title: Topical antiretrovirals to prevent rectal HIV infection Sponsor: University of Pittsburgh |
||
|
Title: Transfusion Medicine/Hemostasis Clinical Trials Network Sponsor: National Institutes of Health (NIH) |
||
|
Title: TRX4_DM_018_US_10 Durable-Response Therapy Evaluation For Early- or New-Onset Type 1 Diabetes (DEFEND-2) Sponsor: Tolerx, Inc. |
||
|
Title: UNC Center for Diabetes Translation Research to Reduce Health Disparities. Sponsor: National Institutes of Health (NIH) |
||
|
Title: UNC Clinical Research Fellowship Program Sponsor: The Doris Duke Foundation |
||
|
Title: University of North Caroilna AIDS Clinical Trials Unit (UNC ACTU) Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: University of North Carolina AIDS Clincial Trials Unit (UNC ACTU) ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: University of North Carolina AIDS Clinical Trials Unit (ACTU)-ARRA Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Using In-host Selection to Determine the Genomics of Artemisinin Resistant Plasmodium falciparum Sponsor: National Institutes of Health (NIH) |
||
|
Title: Using natural language processing to enhance the CONCERT COPD registry Sponsor: Kaiser Permantente Division of Research |
||
|
Title: Validating SOS Targets for Potentiating and Restoring Antibiotic Effectiveness Sponsor: NC Biotechnology Center |
||
|
Title: Variations in Hip Morphology: Frequency and Impact on Osteoarthritis Outcomes Sponsor: National Institutes of Health (NIH) |
||
|
Title: Whole-Exome Sequencing to Define the Genetic Basis of Non-CF Bronchiectasis Sponsor: National Heart Lung and Blood Institute |
||
|
Title: WS426679 Effect of growth hormone on early brain development in girls with Turner Syndrome Sponsor: Pfizer, Inc. |
||
| ||
|
Title: 005/05 A Randomized Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Treatment with OncoVEX Compared to Subcutaneously Administered GM-CSF in Previously Treated Melanoma Patients with Unresectable Stage Illb, IlIc and IV Disease Sponsor: BioVex, Inc. |
||
| Title: 08-110 A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Denufosol Tetrasodium Inhalation Solution in Patients with Cystic Fibrosis Lung Disease and FEV1 >/= 75% but Sponsor: Inspire Pharmaceuticals | ||
|
Title: 082-00 A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy Sponsor: Duke University |
||
|
Title: 1.3 Response to Infliximab for Active Ulcerative Colitis (UC): Repository to Collect Specimens and Clinical Data from UC Patients Receiving Infliximab (REACT Study) Sponsor: Massachusetts General Hospital |
||
|
Title: 1/3 Improving Metabolic Parameters in Antipsychotic Child Treatment ARRA Sponsor: Johns Hopkins University |
||
|
Title: 156-04-251 A Phase 3, Multi-center, Double-blind, Placebo-controlled, Parallel arm Trial to Determine Long-term Safety and Efficacy of Oral Tolvaptan Tablet Regimens in Adult Subjects with Autosomal Dominant Polycystic Kidney Disease Sponsor: Parexel |
||
|
Title: 2/3 Improving Metabolic Parameters of Antipsychotic Child Treatment Sponsor: National Institute of Mental Health-NIH |
||
|
Title: 2993LAR-105 A Randomized, Open-Label, Multicenter Comparator-Controlled Study to Examine the Effects of Exenatide Long-Acting Release on Glucose Control (HBA1C) And Safety in Subjects with Type 2 Diabetes Mellitus Managed with Diet Modification and Exercise And/Or Oral Antidiabetic Medications Sponsor: Amylin Pharmaceutical, Inc. |
||
|
Title: 2993LAR-105 A Randomized Open Label Multicenter Comparator Controlled Study to Examine The Effects of Exenatide Long Action Release on Glucose Control and Safety in Subjects with Type 2 Diabetes Mellitus Managed with Diet Modification and Exercise AND/OR Oral Antidiabetic Medications Sponsor: Amylin Pharmaceutical, Inc. |
||
|
Title: 3201.4414 A Phase II trial of the impact of CYP3A and MDR1 Genotypes on Docetaxel Clearance in Patients with Advanced Epithelial Ovarian Carcinoma or Primary Peritoneal Carcinoma Treated with Intravenous Doxetaxel and Carboplatin Sponsor: Magee-Womens Research Institute Fdn |
||
|
Title: 5-2-1 Almost None Media Campaign Evaluation Sponsor: North Carolina Health and Wellness Trust Commission |
||
|
Title: 901 A Phase II, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of PROCHYMAL (ex vivo cultured adult human mesenchymal stem cells) for the treatment of recently diagnosed type 1 diabetes mellitus (T1DM) Sponsor: Osiris Therapeutics, Inc. |
||
|
Title: A Faith-Based Intervention to Increase Physical Activity Among Blacks Sponsor: Gramercy Research Group |
||
|
Title: A Longitudinal MRI Study of Infants at Risk for Autism Sponsor: National Institute of Child Health and Human Development (NICHD) |
||
|
Title: A Mindfulness-based Intervention to Reduce Diabetes Risk in Prediabetic African-Americans ARRA Sponsor: National Center for Complementary and Alternative Medicine |
||
|
Title: A multicenter, randomized, open label, active-comparator controlled study to assess the efficacy, safety and tolerability of Taspoglutide (RO5073031) compared to exenatide in patients with type 2 diabetes mellitus inadequately controlled with metformin, thiazolidinedione or a combination of both (BC21625) and A multicenter, randomized, open label, active-comparator controlled study to assess the efficacy, safety and tolerability of taspoglutide (RO5073031) compared to exenatide in patients with type 2 diabetes mellitus inadequately controlled with metformin, thiazolidinedione or a bombiation of both (BE21625RG) Sponsor: Hoffman-LaRoche Inc. |
||
|
Title: A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy Sponsor: Mayo Clinic |
||
|
Title: A Phase 2 Study of AZD6244 in Advanced or Metastatic Hepatocellular Carcinoma Sponsor: SAIC-Frederick Inc |
||
|
Title: A Phase I/II Investigation of the Effect of Vorinostat on HIV-1 RNA expression within resting CD4+ T Cells obtained from HIV-infected Patients Receiving Stable Antiretroviral Therapy Sponsor: Merck and Co., Inc. |
||
|
Title: A Pilot Study of Early Postpartum Intrauterine Contraception Sponsor: Society of Family Planning |
||
|
Title: A Randomized Feasibility Trial of a Polypill for Primary Prevention of CVD-AARA Sponsor: National Institutes of Health (NIH) |
||
|
Title: A Randomized, Double-Blind Crossover Study to Evaluate the effect of a very low carbohydrate diet on Gastroesophageal Reflux Disease Sponsor: Takeda Pharmaceuticals North America, Inc. |
||
|
Title: A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs. Cyclophosphamide Aline in the Treatment of Lupus Nephritis Protocol ITN034A1 Sponsor: Immune Tolerance Network |
||
|
Title: A Randomized, Double-Blind, Placebo Controlled Study of the Efficacy of Lithium for the Treatment of Pediatric Mania followed by an Open Label Long-Term Safety Period, Discontinuation Phase, and Restabilization Period (COLT 2) Sponsor: Case Western Reserve |
||
|
Title: A Rheuses Macaque Model of SIV-Malaria Co-Infection Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: A2171121 An observational follow-up study of patients previously enrolled in Exubera controlled clinical trials Sponsor: Pfizer, Inc. |
||
|
Title: AACTG Executive Committee Sponsor: Social and Scientific Systems, Inc |
||
|
Title: ABH-DERMAGRAFT-001-08 A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft in Subjects with Venous Leg Ulcers DEVO-Trial Sponsor: Advanced BioHealing, Inc. |
||
|
Title: Abnormal Interaction Between Executive and Social-Emotional Brain Circuits in Autism Sponsor: Autism Speaks |
||
|
Title: AC063A301 A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients with Symptomatic Pulmonary Arterial Hypertension. Sponsor: Actelion Pharmaceuticals Ltd. |
||
|
Title: AC063a302 A Multicenter, Double-blind, Randomized Study comparing the Safety and Tolerability of Iloprost inhalation solution delivered by I-neb utilizing Power disc-15 and Power disc-6 in Patients with Symptomatic Pulmonary Arterial Hypertension Sponsor: Actelion Pharmaceuticals Ltd. |
||
|
Title: Adapting Project S.A.F.E./Reducing STD/HIV Risk in Women Prisoners Sponsor: Centers for Disease Control and Prevention (CDC) |
||
|
Title: Adapting Project SAFE/Reducing STD/HIV Risk in Women Prisoners Sponsor: Centers for Disease Control |
||
|
Title: Adult Cystic Fibrosis Center Grant Sponsor: Cystic Fibrosis Foundation |
||
|
Title: Advancing patient reported outcomes in children with cystic fibrosis (CF) Sponsor: Seattle Children's Hospital |
||
|
Title: AIDS Clinical Trials Group Network (ACTG) - Task Order Sponsor: Social and Scientific Systems, Inc |
||
|
Title: An Adherence and Depression Intervention for Patients During Hepatitis C Therapy Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: An Observational Study of Postoperative Deep Venous Thrombosis (DVT) in Hemophilics Undergoing Major Orthopedic Surgery Sponsor: CSL Behring Foundation |
||
|
Title: Anti-Viral and Immune Plasma Infrastructure Development Sponsor: Social and Scientific Systems, Inc |
||
|
Title: Antibacterial Potentiation Using RecA Inhibitors Sponsor: Synereca Pharmaceuticals, Inc |
||
|
Title: Antiretroviral Activity and Tolerability of TMC-125 in Treatment-Naive Adults with HIV-1 Infection Sponsor: Tibotec Pharmaceuticals Ltd |
||
|
Title: Appetite Hormone Dysregulation and Racial Ethnic Disparities in Obesity in Women Sponsor: National Institutes of Health (NIH) |
||
|
Title: Application of Organotypic Endometrial Co-culture to Identify a Marker for EIN Sponsor: National Institutes of Health (NIH) |
||
|
Title: ARRA - Carolina-Shaw Comprehensive NCMHD Research Center - Administrative Supplement Sponsor: National Center on Minority Health and Health Disparities (NCMHD) |
||
|
Title: ARRA - Human Requirements for the Nutrient Choline. Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: ARRA - Improving breastfeeding, responsive child care and child spacing through innovative social system network support to reduce maternal and child health disparities Sponsor: National Institutes of Health (NIH) |
||
|
Title: ARRA - Improving the Quality of Medication Use in Older Adults - Administrative Supplement Sponsor: National Institute on Aging |
||
|
Title: ARRA - Incidence, Correlates, and Consequences of Abnormal FMR1 Gene Variants Sponsor: Research Triangle Institute |
||
|
Title: ARRA - SPIO-loaded RL Platelets for Novel Magnetomotive Ultrasound Imaging of Thrombosis Sponsor: National Institutes of Health (NIH) |
||
|
Title: ARRA - Susceptibility and Protective Immunity to Noroviruses Sponsor: National Institutes of Health (NIH) |
||
|
Title: ARRA-Role of Programmed Cell Death10 (PDCD10) in p38 MAP kinase activation and PDK1 signaling Sponsor: National Institutes of Health (NIH) |
||
|
Title: Arthritis & Immunology Sponsor: National Institute of Arthritis Musculoskeletal Skin Disease |
||
|
Title: Assessing and Reducing Post-Deployment Violence Risk Sponsor: National Institutes of Health (NIH) |
||
|
Title: Association of Epstein-Barr virus reactivation with stress in pregnancy Sponsor: National Institutes of Health (NIH) |
||
|
Title: BC21893 A multicenter, randomized, double blind (double dummy), active comparator controlled study to compare the efficacy, safety and tolerability of taspoglutide versus pioglitazone in type 2 diabetes patients inadequately controlled with sulfonylurea (SU) monotherapy or metformin plus sulfonylurea combination therapy Sponsor: Hoffman-LaRoche Inc. |
||
|
Title: BC21893 A multicenter, randomized, double blind (double dummy), active comparator controlled study to compare the efficacy, safety and tolerability of taspoglutide versus pioglitazone in type 2 diabetes patients inadequately controlled with sulfonylurea (SU) monotherapy or metformin plus sulfonylurea combination therapy Sponsor: Hoffman-LaRoche Inc. |
||
|
Title: Benchmarking and the Chronic Care Model in Pediatric Crohn's Disease Sponsor: Children's Digestive Health and Nutrition Foundation |
||
|
Title: BH18387 An Open-Label, Multi-Center Study to Document the Efficacy, Safaety and Tolerability of Long-Term Administration of RO 050-3821 in Patients with Chronic Renal Anemia Sponsor: Hoffman-LaRoche Inc. |
||
|
Title: Biomarkers in Chronic Graft-versus-Host Disease (ARRA) Sponsor: Fred Hutchinson Cancer Research Center |
||
|
Title: Biomarkers of Attachment and Stress in Mothers with Eating Disorders Sponsor: National Institutes of Health (NIH) |
||
|
Title: BLOCK HF Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block Sponsor: Medtronic, Inc |
||
|
Title: Blood cell aggregates and nitric oxide in sickle cell disease ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: C0168Z02 A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients with Inflammatory Bowel Disease Sponsor: Centocor, Inc. |
||
|
Title: C0168Z05 A Phase 4, Multicenter, Open-label, Assessor-blinded, Switch Study of the Efficacy and Safety of Infliximab (REMICADE) in Patients with Active Rheumatoid Arthritis Who are Responding inadequately to Etanercept (Enbrel) or Adalimumab (Humira) Sponsor: Centocor, Inc. |
||
|
Title: C0743T26 A Phase 2b, Multicenter, Randomized, Double-blind, Placebo controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Ustekinumab Therapy in Subjects with Moderately to Severely Active Crohns Disease Previously Treated with TNF Antagonist Therapy Sponsor: Centocor, Inc. |
||
|
Title: C13006 A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission with Vedolizumab (MLN000)2 in Patients with Moderate to Severe Ulcerative Colitis Sponsor: Millennium Pharmaceuticals, Inc. |
||
|
Title: C13007 A Phase 3, Randomized, Placebo-Controlled, Blinded, Multi-center Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients with Moderate to Severe Crohns Disease Sponsor: Millennium Pharmaceuticals, Inc. |
||
|
Title: C13008 A Phase 3, Open-label Study to Determine the Long-Term Safety and Efficacy of Vedolizumab (MLN0002) in Patients with Ulcerative Colitis and Crohns Disease Sponsor: Quintiles, Inc. |
||
|
Title: C87035 A Phase 2, open-label, multicenter study to assess the safety and efficacy of certolizumab pegol in children and adolescents with active Crohns disease (NURTURE Study) Sponsor: Schwarz Biosciences, Inc |
||
|
Title: C87094 A Phase IIIB, multi-center study with a 12 week double-blind, placebo-controlled, randomized period, followed by an open-label extension phase to evaluate the safety and efficacy of certolizumab pegol administered to patients with active rheumatoid arthritis. Sponsor: UCB Pharma, Inc. |
||
|
Title: CAIN457A2202E1 A 52-Week Open Label Extension Study to Evaluate the Safety and Tolerability of AIN457 (Anti IL-17 Monoclonal Antibody) In Patients With Moderate to Severe Crohn's Disease Sponsor: Novartis Pharmaceuticals Corporation |
||
|
Title: Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention Sponsor: Emory University |
||
|
Title: CAM Herbal Cocktail for Boosting Antioxidant Activity to Treat Liver Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Carolina Community Network Sponsor: National Institutes of Health (NIH) |
||
|
Title: Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II) Sponsor: National Institutes of Health (NIH) |
||
|
Title: Carolina Data Warehouse for Health - North Carolina Community Link Sponsor: The Duke Endowment |
||
|
Title: Carolina-Shaw University Comprehensive NCMHD Research Center Sponsor: Natl Ctr Minority Hlth and Hlth Disparities |
||
|
Title: Center for Cardiovascular Health Disparities: Genes, Clinics, and Communities Sponsor: National Institutes of Health (NIH) |
||
|
Title: Center for Genomics and Society Sponsor: National Institutes of Health (NIH) |
||
|
Title: Center for HIV/AIDS Vaccine Immunology (CHAVI) CoreB: CHAVI 001 Sponsor: Duke University |
||
|
Title: Center for HIV/AIDS Vaccine Immunology (CHAVI)-Study 012 Sponsor: Duke University |
||
|
Title: CFAR Network of Integrated Clinical Systems Sponsor: University of Alabama at Birmingham |
||
|
Title: Chemokines: Connecting Stromal Cells to Metastasis Sponsor: American Cancer Society |
||
|
Title: Childhood Trauma in the Adrenergic and HPA-Axis Regulation and Symptoms of PMDD Sponsor: National Institute of Mental Health-NIH |
||
|
Title: CLCL161A2101 A Phase I, multi-center, open-label, dose-escalation study of oral LCL161 in adult patients with advanced solid tumors Sponsor: Novartis Pharmaceuticals Corporation |
||
|
Title: Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemopevention Sponsor: Ohio State University |
||
|
Title: Clinical Research Training in Oral Diseases for Future Sponsor: National Institutes of Health (NIH) |
||
|
Title: Clinical Study of Ursodeoxycholic Acid in Barrett's Patients with Low Grade Dysplasia Sponsor: University of Arizona |
||
|
Title: COAGULATION ACTIVATION IN SICKLE CELL DISEASE ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Collaborative Research: Magneto-optical plasmonic nanoparticles for optical coherence sensing Sponsor: National Science Foundation - Research (NSF) |
||
|
Title: Combined Modality Therapies for the Treatment of Metastatic Breast Cancer Sponsor: Susan G. Komen Breast Cancer Foundation |
||
|
Title: Commercial Development of p16INK4a mRNA as a Blood Biomarker for Molecular Aging Sponsor: G-Zero Therapeutics |
||
|
Title: Communities Putting Prevention to Work Sponsor: County of Mecklenburg |
||
|
Title: Community Health Associate Research and Leadership Institute Sponsor: Children's Hospital of Philadelphia |
||
|
Title: Comparative effectiveness of in-person and telemedicine diabetes self-management - ARRA Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Comparative safety of antiretrovirals among HIV infected patients, minimizing cardiovascular disease outcomes Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Comparing HIV+ Patients and Outcomes by Randomized Clinical Trials Enrollment - ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Comparitive Effectiveness of a Diabetes Self-Management Guide Versus the Guide plus Diabetes Literacy Coaching in High Risk Minority Populations - ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Comprehensive Tobacco Cessation Programs at National Cancer Institute Designated Cancer Centers-ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: CONCERT-Clinical Effectiveness Research (CONCERT-CER) Sponsor: University of Chicago |
||
|
Title: Continuous OC Treatment in PMDD : Steroid Hormone Mechanisms Sponsor: National Institutes of Health (NIH) |
||
|
Title: Cooperative Multicenter Neonatal Research Network Sponsor: Duke University Medical Center |
||
|
Title: COV-BAP01346 Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy Sponsor: Covance Periapproval Services, Inc. |
||
|
Title: CRAD001C2493 A Sequential Phase I Study of the Combination of EverO1ImUs (RAD001) with 5-FU/LV (de Gramont), FOLFOX6, and FOLFOX6/panitumumab in Patients with Refractory Solid Malignancies Sponsor: Novartis Pharmaceuticals Corporation |
||
|
Title: CRD 465 OPTIMISE CRT - Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Cardiac Resynchronization Therapy Sponsor: St. Jude Medical |
||
|
Title: CRO-2009-GIN-01-RR Triclosan Effects On Inflammatory And Epigenetic Markers of Gingivitis Sponsor: Colgate Palmolive Company |
||
|
Title: CTRC-1419 A Study of Long-Term Human Recombinant Insulin-Like Growth Factor-I (rhIGF-I) Treatment in Children with Short Stature Due to Growth Hormone Insensitivity Syndrome (GHIS) Sponsor: Tercica, Inc. |
||
|
Title: CTRIP Ex-vivo perfusion and ventilation of lungs to assess transplant suitability Sponsor: National Institutes of Health (NIH) |
||
|
Title: Depression, Estrogen Replacement and Cardiovascular Health in the Perimenopause Sponsor: National Institutes of Health (NIH) |
||
|
Title: Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause Sponsor: National Institutes of Health (NIH) |
||
|
Title: Developing magnetomotive ultrasound to contrast SPIO-loaded RL platelets Sponsor: National Institutes of Health (NIH) |
||
|
Title: Dietary control and Motility in adolescents with IBS Sponsor: American College of Gastroenterology |
||
|
Title: Differential regulation of autoimmune Th17 cells by dendritic cell subsets Sponsor: National Institutes of Health (NIH) |
||
|
Title: DJN608b 2302 A multinational, randomized, double-blind, placebo-controlled, forced-titration, 2 x 2 factorial design study of the efficacy and safety of long term administration of nateglinide and valsartan in the prevention of diabetes and cardiovascular outcomes in subjects with impaired glucose tolerance (IGT) Sponsor: Novartis Pharmaceuticals Corporation |
||
|
Title: DMHEALTH: FEASIBILITY OF A CELL-PHONE ADHERENCE TRIAL FOR UNDERSERVED T1DM YOUTH Sponsor: National Institutes of Health (NIH) |
||
|
Title: DODS - D-dimer Optimal Duration Study Sponsor: McMaster University |
||
|
Title: Domestic Science Education Partnership Award Sponsor: East Carolina University |
||
|
Title: Dopamine release and gene expression in an animal model of binge eating Sponsor: The Klarman Family Foundation |
||
|
Title: Dopaminergic Modulation of Immediate Reward Bias Sponsor: National Institutes of Health (NIH) |
||
|
Title: DRC-0651 Studies of Clinical and Biofilm Responses in Human Gingivitis and periodontitis: Effects of Sonicare-Flexcare Sponsor: Philips Oral Healthcare, Inc. |
||
|
Title: Drug-Induced Liver Injury Network (DILIN)" Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: DU176b-C-U301 A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of DU-176b Versus Warfarin In Subjects with Atrial Fibrillation Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation Sponsor: Quintiles, Inc. |
||
|
Title: Effect of HIV infection and antiretroviral therapy on cerebral autoregulation Sponsor: National Institutes of Health (NIH) |
||
|
Title: Effect of Weight - Increased Psychotropic Medications on Appetite Regulation Sponsor: National Institute of Mental Health-NIH |
||
|
Title: Effectiveness of Obstructive Sleep Apnea Diagnostic Processes in Primary Care Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Effects of Orthotics and Balance Training on Balance, Falls, and Quality of Life Sponsor: National Institutes of Health (NIH) |
||
|
Title: Eliminating Disparities of Women's Preventive Healthcare Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Elucidation of immunostimulatory properties of a simple vaccine for cervical cancer, combination of the vaccine with gene therapy and application of the adjuvant in the development of a vaccine for melanoma Sponsor: Pharmaceutical Research and Manufacturers of America Fdn,Inc |
||
|
Title: Enhancing Group Identify May Improve Effectiveness of Diabetes
Self-Management Education Sponsor: Advanced TeleCare, LLC |
||
|
Title: Enhancing Physician's Adherence to HAART Treatment Guidelines Sponsor: National Institute of Mental Health-NIH |
||
|
Title: Enumerating the Community Burden of Heart Failure Sponsor: National Institutes of Health (NIH) |
||
|
Title: EPIC-002 EPIC Observational Study Sponsor: Seattle Children's Hospital |
||
|
Title: Eptifibatide as Treatment for Acute Pain Episodes in Sickle Cell Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Estimation of High Dimensional Dynamic Gene Networks from Time Series Observations Sponsor: National Institutes of Health (NIH) |
||
|
Title: Ethical Approaches to Genotype-Driven Research Recruitment Sponsor: Duke University |
||
|
Title: Exposure to antibiotics during infancy and subsequent risk of Crohn's disease: a population-based birth cohort study Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: Factor XIII Concentrate (Human) (Fibrogammin P) for Treatment of Factor Deficiency Sponsor: Children's Hospital of Orange County |
||
|
Title: FAM83H Gene Function and Amelogensis Imperfecta Phenotypes Sponsor: National Institutes of Health (NIH) |
||
|
Title: Familial Barrett's Esophagus Sponsor: Case Western Reserve |
||
|
Title: Feasibility and Effect of a virtually supported, community-based fitness and wellness program on activity level, participation and functional outcomes in adults with cerebral palsy. Sponsor: Cerebral Palsy Foundation |
||
|
Title: Fecal Microflora in Irritable Bowel Syndrome (IBS): Characterization and Significance Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: Food Environment as a Determinant in Weight and Diet Change among Women Sponsor: National Center for Chronic Disease Prev and Health Promo(CDC) |
||
|
Title: From Specimen To Biobank: Using An Organizational Perspective To Study ELSI Issues Sponsor: National Institutes of Health (NIH) |
||
|
Title: FSH as a Biomarker of Bone Strength in Younger Postmopausal Women Sponsor: National Institute of Arthritis Musculoskeletal Skin Disease |
||
|
Title: Function BIRN Sponsor: University of California at Irvine |
||
|
Title: Functional and Structural Neuroimaging of Social and Executive Circuits in Autism Sponsor: National Institutes of Health (NIH) |
||
|
Title: Functional Neuroimaging of Psychopharmacologic Intervention for Autism Sponsor: National Institutes of Health (NIH) |
||
|
Title: Functional Ploymorphism Analysis in Drug Pathways Sponsor: National Institute of General Medicine Science |
||
|
Title: Functionalized Amino Acid Amides: Novel Anticonvulsants with Diverse Activities Sponsor: National Institutes of Health (NIH) |
||
|
Title: GC-002US A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in combination with Sorafenib (Nexavar) in Patients with Advanced or Metastatic Hepatocellular Carcinoma (HCC). Sponsor: Averion International Corp |
||
|
Title: Gene Modifiers in CF Lung Disease Sponsor: National Heart Lung and Blood Institute |
||
|
Title: Gene Targets for IVH-ARRA Sponsor: Yale University |
||
|
Title: Gene-Environment Interactions in the Development of Post-Infectious Irritable Bowel Syndrome (ARRA) Sponsor: National Institutes of Health (NIH) |
||
|
Title: Genome-Wide Association Study of Periodontal Disease-ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Genomics of Acute Myelogenous Leukemia Sponsor: Washington University @ St. Louis, Mo. |
||
|
Title: Genomics, Genetics, and Clinical Breast Cancer Behavior Sponsor: Breast Cancer Research Foundation |
||
|
Title: GS-US-207-0103 A Phase 2, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis and Pseudomonas aeruginosa Sponsor: Gilead Sciences, Inc. |
||
|
Title: GS-US-235-0101 A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-ranging Study of Cicletanine in Subjects with Pulmonary Arterial Hypertension Sponsor: Gilead Sciences, Inc. |
||
|
Title: GS-US-300-0117 A Randomized, Multicenter Study of Ambrisentan and Sildenafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension who have Demonstrated a Sub-Optimal Response to Sildenafil ATHENA-1: Sponsor: Gilead Sciences, Inc. |
||
|
Title: H8O-US-GWCO A Randomized Trial Comparing Exenatide with Placebo in Subjects with Type 2 Diabetes on Insulin Glargine With or Without Oral Antihyperglycemis Medications Sponsor: Eli Lilly and Co. |
||
|
Title: HALO-117-203 A Phase II, Randomized, Open Label, 2-Way Crossover, Safety Study of Subcutaneously Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Patients wtih Type 1 Diabetes Sponsor: Halozyme, Inc. |
||
|
Title: HGS-1012-C1077 A Two-stage, Multi-center, Open-label study of Mapatumumab ([HGS1012], A Fully-human Monoclonal Antibody to Trail-R1) in Combination with Sorafenib as a First-line Therapy in Subjects with Advanced Hepatocellular Carcinoma Sponsor: Human Genome Sciences, Inc. |
||
|
Title: HGS1006-C1056 A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects with Systemic Lupus Erythematosus (SLE) who Completed the Phase 3 Protocol HGS1006-C1056 in the United States. Sponsor: Human Genome Sciences, Inc. |
||
|
Title: HGT-HIT-045 A Phase I/II Randomized Safety and Ascending Dose Ranging Study of Idursulfase (Intrathecal) Administration via an Intrathecal Drug Delivery Device in Pediatric Patients with Hunter Syndrome Who Demonstrate Evidence of Central Nervous System Involvement and Who Are Receiving Treatment with Elaprase Sponsor: Shire Human Genetic Therapies, Inc. |
||
|
Title: HGT-HIT-050 A Screening Study to Identify Pediatric Patients with Hunter Syndrome Who Demonstrate Evidence of Central Nervous System Involvement and Who are Currently Receiving Treatment with Elaprase Sponsor: Shire Human Genetic Therapies, Inc. |
||
|
Title: HIV Latency, Epigenetics, and Therapeutics Sponsor: National Institute on Drug Abuse |
||
|
Title: HIV Prevention Trials Network (HPTN) Leadership Sponsor: Family Health International |
||
|
Title: HQP 2008-204 A Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK 1001 in Subjects with Sickle Cell Disease Sponsor: HemaQuest Pharmaceuticals, Inc. |
||
|
Title: Human Requirements for the Nutrient Choline Sponsor: National Institutes of Health (NIH) |
||
|
Title: Human Requirements for the Nutrient Choline Supplement (5R01DK055865):
Choline Metabolism and Non-Alcoholic Fatty Liver Disease in Obesity Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: Immediate ART in Acute HIV: Attacking the Pathogenesis of Persistent Infection Sponsor: National Institutes of Health (NIH) |
||
|
Title: Immediate ART in Acute HIV: Attacking the Pathogenesis of Persistent Infection - ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Immersive Virtual Environments for Physical Rehabilitation ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Immunobiology of Acute Environmental Asthma - ARRA Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Impact of malnutrition on TB-IRIS and pharmacokinetics of TB and ARV co-treatment Sponsor: National Institutes of Health (NIH) |
||
|
Title: Impact of Periodontal Therapy on Metabloic and Inflammatory markers in Chronic Kidney Disease Patients Sponsor: OraPharma, Inc. |
||
|
Title: Impact of Social Factors on the Effectiveness of a Preconceptional PTB Program Sponsor: National Institutes of Health (NIH) |
||
|
Title: Improving Decision-Making about Feeding Options for Dementia Patients Sponsor: National Institute of Nursing Research |
||
|
Title: Improving the Quality of Medication Use in Older Adults Sponsor: National Institutes of Health (NIH) |
||
|
Title: Increasing access to good food for all North Carolina citizens while rebuilding a local sustainable food economy and engaging youth Sponsor: North Carolina State University |
||
|
Title: Infectious Disease Pathogenesis Research Training Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Inflammatory Bowel Disease Sinai-Helmsley Alliance for Research Excellence (SHARE) Network Sponsor: Mt. Sinai School of Medicine |
||
|
Title: ING112961 A Phase IIb pilot study to assess the antiviral activity of GSK1349572 containing regimen in antiretroviral therapy (ART)-experienced, HIV-1 infected adult subjects with raltegravir resistance Sponsor: GlaxoSmithKline, Inc |
||
|
Title: Innovative therapies to eliminate persistent HIV infection ARRA Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Interventions for Preventing and Managing Chronic Illness Sponsor: National Institute of Nursing Research |
||
|
Title: IP102 A Clinical Evaluation of the Medtronic Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm Sponsor: Medtronic Vascular, Inc. |
||
|
Title: IRUS33550002: Do Acid Sensing Ion Channels (ASICs) Contribute to Heartburn in Patients with Proton Pump Inhibitor (PPI)-Complete Responders or PPI-Partial Responders with Non-erosive Reflux Disease (NERD)? Sponsor: Astra/Zeneca |
||
|
Title: L33400546 An Exploratory Study of Denture Stomatitis to Characterize the Mucosal Gene Expression Profile, Levels of Salivary Cytokines and the Mucosal and Denture Surface Biofilm Composition Sponsor: GlaxoSmithKline, Inc |
||
|
Title: L33400546 An Exploratory Study of Denture Stomatitis to Characterize the Mucosal Gene Expression Profile, Levels of Salivary Cytokines and the Mucosal and Denture Surface Biofilm Composition Sponsor: GlaxoSmithKline, Inc |
||
|
Title: LCCC 0715 A Dose Escalation Study of Bortezomib (Velcade), Pegylated Liposomal Doxorubicin (Doxil), and Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA, ZolinzaTM) in Patients with Relapsed/Refractory Multiple Myeloma Sponsor: Merck and Co., Inc. |
||
|
Title: Longitudinal Studies of Child Abuse and Neglect: NC Site (LONGSCAN) Sponsor: Administration for Children, Youth and Families |
||
|
Title: Lung Cancer Surgery: Decisions Against Life Saving Care -- The Intervention Sponsor: American Cancer Society |
||
|
Title: M06-807 A Multi-Center, Open-Label, Study of the Human Anti-TNF Monclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-Term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who have Demonstrated a Clinical Response in the M06-806 Study Sponsor: Abbott Laboratories Corp. |
||
|
Title: Magneto-Optical Nanoparticles for 3D Visco-Elasticity Imaging of Breast Cancer Sponsor: National Institutes of Health (NIH) |
||
|
Title: Magnetomotive ultrasound system to monitor and activate SPIO-loaded RL platelets Sponsor: Office of Naval Research |
||
|
Title: Malawi Clinical Trials Unit Sponsor: Johns Hopkins University |
||
|
Title: Maternal Feeding Responsiveness and Risk of Obesity from Infancy through Early Childhood Sponsor: Robert Wood Johnson Foundation |
||
|
Title: Maternal Oral Therapy to Reduce Obstetric Risk (MOTOR) Sponsor: National Institutes of Health (NIH) |
||
|
Title: Measuring Decision Quality: A Prospective, Longitudinal Study in Breast Cancer Sponsor: Massachusetts General Hospital |
||
|
Title: Mechanisms of chromatin regulation that drive HIV latency Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Mechanisms Underlying Drug Diet Interactions Sponsor: National Institutes of Health (NIH) |
||
|
Title: Medical Scientist Training Program Sponsor: National Institute of General Medicine Science |
||
|
Title: Metabolites and Secreted Proteins for Early Detection of Pancreas Cancer - ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Metformin as a Novel Chemotherapeutic Strategy for Endometrial Cancer Sponsor: American Cancer Society |
||
|
Title: Metformin as a Novel Chemotherapeutic Strategy for Endometrial Cancer Sponsor: American Association for Cancer Research |
||
|
Title: Metformin as a Novel Chemotherapeutic Strategy for Endometrial Cancer. Sponsor: American Cancer Society |
||
|
Title: Methods and measures of combined oral contraceptives in HIV-infected women using antiretrovirals Sponsor: National Institutes of Health (NIH) |
||
|
Title: Microbial induced Epigenetic Modification of Periodontal Mucosa-ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mindfulness for Irritable Bowel Syndrome - ARRA Sponsor: National Center for Complementary and Alternative Medicine |
||
|
Title: Molecular Markers of Endometrial Intraepithelial Neoplasia Sponsor: National Institutes of Health (NIH) |
||
|
Title: Molecular Mechanisms Associated with b2AR Regulation in Parkinson's Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Molecular Phenotypes for Cystic Fibrosis Lung Disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: MOTOR - Maternal Oral Therapy to Reduce Obstetric Risk and Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: Mucociliary Clearance in PCD Patients wiht Normal Ciliary Ultrastructure Sponsor: American Thoracic Society |
||
|
Title: NAI113678 An open-label, Multi-Center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects with Confirmed Influenza Infection. NAI1113678 Sponsor: GlaxoSmithKline, Inc |
||
|
Title: National Alliance for Medical Image Computing (NAMIC) Sponsor: Brigham and Women's Hospital |
||
|
Title: Neurobiology of Selective Attention in Schizophrenia Sponsor: National Institutes of Health (NIH) |
||
|
Title: Neurobiology of Selective Attention in Schizophrenia (ARRA) Sponsor: National Institute of Mental Health-NIH |
||
|
Title: NF-kB as an in vitro Target for Parkinson's Disease Therapy Sponsor: TheraLogics |
||
|
Title: NHLBI Lung Cohorts Sequencing Project Sponsor: University of Washington |
||
|
Title: NN1250-3583 A 52 week randomized, controlled, open label, multicenter, multinational, parallel, treat-to-target trial comparing efficacy and safety of SIBA and insulin glargine both administered once daily in a basal-bolus regimen with insulin aspart as mealtime insulin in subjects with type 1 diabetes Sponsor: Novo Nordisk Pharmaceuticals, Inc. |
||
|
Title: NO22068RG Phase Ib Study To Evaluate The Safety Of Combining IGF-1R Antagonist R1507 With Multiple Standard Chemotherapy Drug Treatments In Patients With Advanced Malignancies Sponsor: Hoffman-LaRoche Inc. |
||
|
Title: O3 and LPS-Induced Airway Inflammation in Humans In Vivo Sponsor: National Institute of Environmental Health Sciences |
||
|
Title: O3 and LPS-Induced Airway Inflammation in Humans In Vivo - ARRA Sponsor: National Institute of Environmental Health Sciences |
||
|
Title: Obesity prevention through weight management, improved food access, and increased food preparation skills in underserved communities Sponsor: US Department of Agriculture |
||
|
Title: Obesity Prevention White Paper Sponsor: Moses Cone-Wesley Long Community Health Foundation |
||
|
Title: OMB110927 A Single Arm, Safety and Efficacy Study of Ofatumumab in Combination with ICE or DHAP Chemotherapy in Relapsed or Refractory Aggressive Lymphoma Prior to Autologous Stem Cell Transplantation Sponsor: GlaxoSmithKline, Inc |
||
|
Title: Optimizing Technology in the Treatment of Bulimia Nervosa Sponsor: National Institutes of Health (NIH) |
||
|
Title: Optimizing Technology in the Treatment of Bulimia Nervosa (ARRA) Sponsor: National Institutes of Health (NIH) |
||
|
Title: Oxytocin Treatment of Social Deficits and Psychotic Symptoms in Schizophrenia Sponsor: The Stanley Medical Research Institute |
||
|
Title: P12/722053 Prospective, Randomized, Two-arm Study to Compare the Efficacy of the Medtronic MiniMed Paradigm REAL-time System Versus Multiple Daily Injection (MDI) in Subjects with Type 1Diabetes Mellitus Naive to Insulin Pump Therapy Sponsor: Medtronic MiniMed, Inc. |
||
|
Title: Pathogenesis of PCD Lung Disease Sponsor: National Heart Lung and Blood Institute |
||
|
Title: Pathophysiological mechanisms underlying freezing of gait and sensory cues in Parkinson's disease pateints: a SPECT/CT study Sponsor: Michael J. Fox Foundation |
||
|
Title: Phase II Evaluation of CD-34 Positive Cells in Treatment of CLI ARRA Sponsor: Northwestern University |
||
|
Title: Phenotype and Gene Expression in Odontogenic Tumors Sponsor: National Institutes of Health (NIH) |
||
|
Title: Phenotypic Probes for Predicting Doxil Pharmacokinetics and Pharmacodynamics Sponsor: Hematology and Oncology Pharmacy Association |
||
|
Title: Phenotypic Probes for the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Nanoparticle Agents-ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Physiological Effects of Probiotic Bacteria Lactobacillus Acidophilus NCFM Alone Versus a Combination with Bifidobacterium Lactids -LBi07 in Patients with Mild to Moderate Abdominal Pain/Discomfort and Bloating Sponsor: Danisco USA, Inc. |
||
|
Title: Physiological Effects of Yogurt containing Bifidobacterium lactis (Bb12) in Subjects with Non-diarrhea Functional Gastrointestinal Symptoms Sponsor: General Mills |
||
|
Title: Pilot Studies of Gene Therapy for Primary Ciliary Dyskinesia - ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Platelets and inflammation in sickle cell anemia Sponsor: American Heart Association - Mid Atlantic Affiliate |
||
|
Title: Predicting Omega-6 and Omega-3 Status in whole blood and tissues at linoleic acid intakes below 3 percent of energy: Validation of Lands' empirical equation in ambulatory subjects with Chronic Daily Headache - ARRA Sponsor: Office of the Director, National Institutes of Health |
||
|
Title: Prenatal Cocaine, Smoking and Oxytocin in Humans Sponsor: National Institute on Drug Abuse |
||
|
Title: Preventing exposure to ticks and tick-borne illness in outdoor workers Sponsor: Centers for Disease Control and Prevention (CDC) |
||
|
Title: Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Primary Care and Communities Tackling Obesity in Kids Sponsor: NIH Clinical Center |
||
|
Title: Prior Depression, PMDD, and Pain: Biological Mechanisms Sponsor: National Institutes of Health (NIH) |
||
|
Title: PROMIS Pediatrics: Longitudinal Validation and Linking Pediatric and Adult Item Banks Sponsor: National Institute of Arthritis Musculoskeletal Skin Disease |
||
|
Title: Psychophysiology of Irritable Bowel Syndrome ARRA Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: Psychophysiology of irritable Bowel Syndrome: ARRA Summer Research Supplement Sponsor: National Institutes of Health (NIH) |
||
|
Title: Psychophysiology of Irritable Bowel Syndrome: Competitive Revision-ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: PT090084-"Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury" Sponsor: US Department of Defense |
||
|
Title: Pulmonary vascular remodeling in a murine model of congenital diaphragmatic hernia Sponsor: March of Dimes Foundation |
||
|
Title: Pulmonary Vascular Remodeling Leads to Pulmonary Hypertension in a Mouse Model for Congenital Diaphragmatic Hernia Sponsor: American Surgical Association Foundation |
||
|
Title: Radiation-Induced Signaling and Treatment Resistance Sponsor: National Institutes of Health (NIH) |
||
|
Title: Radionuclide Decorporation with an Orally Bioavailable Prodrug of DTPA Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Randomized Trial of Surgery/Medical Treatment for Diabetes Sponsor: East Carolina University |
||
|
Title: Reaching inaccessible anatomy percutaneously via multi-lumen steerable needles Sponsor: Vanderbilt University |
||
|
Title: Recovery Act 2009 Limited Competition: AHRQ Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) Grants (R01) Sponsor: University of Chicago |
||
|
Title: Reducing Disparities in Exclusive Breastfeeding by Identifying Modifiable Population-specific Obstacles Sponsor: Health Resources and Services Administration |
||
|
Title: Reducing Inappropriate Prescribing of Antibiotics by Primary Care Clinicians Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Regulating Inflammation in Composite Osteoblast-Osteoclast Nano-Engineered Bone Sponsor: National Institute of Dental and Craniofacial Research |
||
|
Title: Regulation of Adiponectin Action by mTOR and TOA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Regulation of cell adhesion in sickle cell disease Sponsor: National Institutes of Health (NIH) |
||
|
Title: Regulation of the physiologic and pathologic activation of the NLRP3-inflammasome Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Representational Intervention to Promote End-of-Life Decision-Making Preparation Sponsor: National Institutes of Health (NIH) |
||
|
Title: Repression of HIV Transcription: from mechanisms to anti-latency therapies-ARRA Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Reproducibility and Clinical Implications of Masked Hypertension Sponsor: National Institutes of Health (NIH) |
||
|
Title: Respiratory Periodicity and Cognitive Decline in Elders Sponsor: National Institute of Nursing Research |
||
|
Title: Respiratory Periodicity during Sleep and Neural Reserve in Old and Young Adults Sponsor: National Institute of Nursing Research |
||
|
Title: Restoring Epithelial-Stromal Interactions to Suppress Endometrial Cancer Growth- ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: RFIB3007 A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin 550 Mg TID in the Treatment of Subjects with Non-Constipation Irritable Bowel Syndrome Sponsor: Salix Pharmaceuticals, Inc. |
||
|
Title: Robeson County Bridges for Families and Perinatal and Maternal SA Initiative Sponsor: Governor's Institute on Alcohol and Substance Abuse... |
||
|
Title: Role of CX3CR1 in vascular inflammation Sponsor: Arthritis Foundation |
||
|
Title: Role of IKKbeta inhibitor in Parkinson's Disease Sponsor: TheraLogics |
||
|
Title: ROR2 as a Target for Renal Carcinoma-ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Rural obesity and related economic and environmental factors Sponsor: East Carolina University |
||
|
Title: Salivary proteomic study for oropharyngeal and esophageal candidiasis in HIV-infected patients: an exploratory study Sponsor: National Institutes of Health (NIH) |
||
|
Title: SCCOR in Host Factors in Chronic Lung Disease Sponsor: National Heart Lung and Blood Institute |
||
|
Title: Selective screening for osteoporosis in younger postmenopausal women Sponsor: National Center for Research Resources |
||
|
Title: Sequencing 1,000 Candidate Ciliome Genes in Primary Ciliary Dyskinesia Patient Sponsor: University of Pittsburgh |
||
|
Title: Sex Differences in Early Brain Development; Brain Development in Turner Syndrome Sponsor: National Institutes of Health (NIH) |
||
|
Title: Sex, Aging and Antiretroviral Pharmacology Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: SFRP2 and NFAT are therapeutic targets in angiosarcoma Sponsor: National Institutes of Health (NIH) |
||
|
Title: SL0008 A Phase IIB, Multicenter, open label, follow up study to assess the safety and efficacy of Epratuzumab in serologically-positive systemtic lupus erythematosus patients with active disease who participanted in study SL0007 Sponsor: PPD Development, Inc |
||
|
Title: SmartPill Colonic Transit Time Validation Study in Patients with Chronic Constipation Sponsor: The SmartPill Corporation |
||
|
Title: Smooth Muscle Cell Related Mechanisms of Pulmonary Hypertension in Congenital Diaphragmatic Hernia Sponsor: Robert Wood Johnson Foundation |
||
|
Title: Smooth muscle cell related vascular remodeling in pulmonary hypertension in congenital diaphragmatic hernia Sponsor: Actelion Pharmaceuticals Ltd. |
||
|
Title: Statistical Methods for Cancer Clinical Trials Sponsor: National Cancer Institute |
||
|
Title: Study of Secondary Conditions and Effects of Aquatic Intervention in Adult CP Sponsor: National Institute of Child Health and Human Development (NICHD) |
||
|
Title: Studying Community Programs to Reduce Childhood Obesity Sponsor: Macro International |
||
|
Title: Suncontract with NORC at the University of Chicago: Provider and Payor Tools for Assessing Healthy Behavior, Promoting Healthy Lifestyle, and Reducing Healthcare Cost Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: SWHI-03 A Long-Term Follow-up Study of Subjects Who Were Previously Enrolled in Tissue Repair Company-Sponsored Clinical Trials Using GAM501 Sponsor: Tissue Repair Company |
||
|
Title: System Dynamics Modeling to Inform Overweight and Obesity-relevant Policy Sponsor: Virginia Polytechnic Institute |
||
|
Title: Targeting Persistent HIV Infection Sponsor: National Institute on Drug Abuse |
||
|
Title: Teaching Pediatric Patients to Read Food and Prescription Labels with a Web-based Videogame (ARRA) Sponsor: National Institutes of Health (NIH) |
||
|
Title: Telehealth technologies to improve adherence to diabetes care guidelines. ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Effect of the Probiotic Bacteria Lactobacillus acidophilus NCFM on Intestinal Pain-Modulating Receptors and Pain Sensation Thresholds in Patients with Irritable Bowel Syndrome Sponsor: National Center for Complementary and Alternative Medicine |
||
|
Title: The impact of three smoking related vital signs in the electronic medical record on documented smoking cessation counseling Sponsor: National Institutes of Health (NIH) |
||
|
Title: The in vivo effect of HDAC inhibitors on HIV gene expression in resting CD4+ T cells Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: The Internalizing Pathway to Substance Use Disorders: From Etiology to Prevention Sponsor: National Institutes of Health (NIH) |
||
|
Title: The Pharmacodynamics of Genes and Oligonucleotides Sponsor: National Institute of General Medicine Science |
||
|
Title: The Role of IGFBP-2 in Adipogenesis Sponsor: Endocrine Fellows Foundation |
||
|
Title: The Role of Intestinal Inflammation in the Pathophysiology of IBS Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: The Role of Intestinal Inflammation in the Pathyphysiology of IBS - ARRA Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases |
||
|
Title: The Sickle Cell Disease Clinical Research Network Grant Sponsor: New England Research Institutes |
||
|
Title: The Vest Prevention of Early Sudden Death Trial (VEST) and PREDiction of ICD Therapies Study (PREDICTS) Sponsor: University of California at San Francisco |
||
|
Title: Third Molar Clinical Trials Sponsor: Oral and Maxillofacial Surgery Foundation |
||
|
Title: TINSAL T2D Targeting Inflammation Using Salsalate for Type 2 Diabetes: Clinical Trial Stage 2 Sponsor: Joslin Diabetes Center, Inc. |
||
|
Title: TMB-202 A Phase 2, Randomized, Double-Blinded, 48-Week, Multicenter, Dose-Response Study of Ibalizumab Plus and Optimized Background Regimen in Treatment-Experienced Patients Infected with HIV-1 Sponsor: Numoda Corporation |
||
|
Title: TMC114HIV3015 A single arm, open label study to assess the pharmacokinetics of darunavir/ritonavir and/or etravirine in HIV-1 infected pregnant women Sponsor: Tibotec Pharmaceuticals Ltd |
||
|
Title: TMC125HIV4002 Antiretroviral Activity and Tolerability of TMC-125 in Treatment-Naive Adults with HIV-1 Infection Sponsor: Tibotec Pharmaceuticals Ltd |
||
|
Title: TNG-UNC-001 Human Kidney Cell Isolation, Characterization, & Expansion (ICE) Study Sponsor: Tengion |
||
|
Title: Transdermal DTPA Prodrug for Radionuclide Decorporation Sponsor: Capture Pharmaceuticals, LLC |
||
|
Title: Transforming Health and Behavioral Interventions to Address the Social Determinants of Disparities in Infant Mortality - ARRA Sponsor: National Institutes of Health (NIH) |
||
|
Title: Transforming Primary Care Practice in North Carolina Sponsor: Agency for Healthcare Research and Quality |
||
|
Title: Transfusion Medicine/Hemostasis Clinical Trials Network Sponsor: National Heart Lung and Blood Institute |
||
|
Title: Translating Research to Practice: a Collaborative Model for Obesity Prevention Sponsor: National Center for Chronic Disease Prev and Health Promo(CDC) |
||
|
Title: Translational Characterization of the Cytochrome P450 Epoxygenase Pathway in Atherosclerosis Sponsor: American Heart Association - Mid Atlantic Affiliate |
||
|
Title: Translational Research Center for CAM Therapy of Asthma - ARRA Sponsor: National Center for Complementary and Alternative Medicine |
||
|
Title: TRX4_DM_006_08 Durable-Response Therapy Evaluation for Early- or New-Onset Type 1 Diabetes DEFEND -1 Sponsor: Tolerx, Inic. |
||
|
Title: UCAN: Uniting Couples (in the treatment of) Anorexia Nervosa Sponsor: National Institutes of Health (NIH) |
||
|
Title: UNC BIRCWH Career Development Program Sponsor: National Institute of Child Health and Human Development (NICHD) |
||
|
Title: UNC Center for AIDS Research (CFAR) Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: UNC Comprehensive Sickle Cell Program Sponsor: North Carolina Dept of Health and Human Services |
||
|
Title: UNC Comprehensive Sickle Cell Program Sponsor: North Carolina Division of Public Health |
||
|
Title: UNC Developmental Disabilities Research Center Sponsor: National Institute of Child Health and Human Development (NICHD) |
||
|
Title: UNC HIV Oral Health Demonstration Project Sponsor: Health Resources and Services Administration |
||
|
Title: University of North Carolina AIDS Clinical Trials Unit (UNC ACTU) Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: University of North Carolina AIDS Clinical Trials Unit (UNC ACTU) - ARRA Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Vaginal/Rectal HIV Transmission Model Sponsor: National Institute of Allergy and Infectious Diseases |
||
|
Title: Variation in the clinical outcomes of pediatric Crohn's disease and development of a tool to assess delivery of chronic illness care Sponsor: Crohn's and Colitis Foundation of America, Inc. |
||
|
Title: VX08-770-102 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficay and Safety of VX-770 in Subjects with Cystic Fibrosis and the G55D1 Mutation Sponsor: Vertex Pharmaceuticals, Inc. |
||
|
Title: VX08-809-101 A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the F508-CFTR Gene Mutation Sponsor: Vertex Pharmaceuticals, Inc. |
||
|
Title: W0027-10 A Phase 2, Randomized, Double-Blind, Placebo- Controlled, Parallel-Group, Dose-Ranging Study to Investigate the Efficacy and Safety of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis Sponsor: Stiefel Laboratories, Inc. |
||
|
Title: Web Portal and Collaboration Platform for Rural Health Care Providers Sponsor: MedCommunities, Inc. |
||
|
Title: Web-Based Wellness Policy Toolkit for Obesity Prevention in Middle Schools Sponsor: Cirque Productions, LLC |
||
|
Title: Within Host Selection of P. falciparum Variants by Artemisinin Combination Therapies Sponsor: National Institutes of Health (NIH) |
||